WO2024005199A1 - Method for producing composition comprising exosome, and composition comprising diacylglycerol-containing exosome - Google Patents
Method for producing composition comprising exosome, and composition comprising diacylglycerol-containing exosome Download PDFInfo
- Publication number
- WO2024005199A1 WO2024005199A1 PCT/JP2023/024458 JP2023024458W WO2024005199A1 WO 2024005199 A1 WO2024005199 A1 WO 2024005199A1 JP 2023024458 W JP2023024458 W JP 2023024458W WO 2024005199 A1 WO2024005199 A1 WO 2024005199A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fish
- exosomes
- water
- salmon
- diacylglycerol
- Prior art date
Links
- 210000001808 exosome Anatomy 0.000 title claims abstract description 120
- 239000000203 mixture Substances 0.000 title claims abstract description 80
- 150000001982 diacylglycerols Chemical class 0.000 title claims abstract description 56
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 40
- 241000251468 Actinopterygii Species 0.000 claims abstract description 103
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 78
- 238000000034 method Methods 0.000 claims abstract description 31
- 235000019688 fish Nutrition 0.000 claims description 100
- 241000277331 Salmonidae Species 0.000 claims description 26
- 239000002245 particle Substances 0.000 claims description 26
- 210000000988 bone and bone Anatomy 0.000 claims description 22
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 18
- 229930195729 fatty acid Natural products 0.000 claims description 18
- 239000000194 fatty acid Substances 0.000 claims description 18
- 150000004665 fatty acids Chemical class 0.000 claims description 18
- 230000008569 process Effects 0.000 claims description 11
- 241000277275 Oncorhynchus mykiss Species 0.000 claims description 10
- 239000002504 physiological saline solution Substances 0.000 claims description 8
- 241001280377 Oncorhynchus tshawytscha Species 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 241000972773 Aulopiformes Species 0.000 claims description 6
- 241000277329 Oncorhynchus keta Species 0.000 claims description 5
- 241000277338 Oncorhynchus kisutch Species 0.000 claims description 5
- 241000277269 Oncorhynchus masou Species 0.000 claims description 5
- 241000277277 Oncorhynchus nerka Species 0.000 claims description 5
- 241001507086 salmonid fish Species 0.000 claims description 4
- 241001092070 Eriobotrya Species 0.000 claims description 3
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims description 3
- 238000011282 treatment Methods 0.000 description 33
- 239000007788 liquid Substances 0.000 description 25
- 210000003491 skin Anatomy 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- 235000013305 food Nutrition 0.000 description 11
- 210000003128 head Anatomy 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- 239000000523 sample Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 241000277263 Salmo Species 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 239000002105 nanoparticle Substances 0.000 description 5
- 235000019515 salmon Nutrition 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 241000442132 Lactarius lactarius Species 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000007667 floating Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000262731 Oncorhynchus kawamurae Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241001454698 Teleostei Species 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 235000014102 seafood Nutrition 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 235000001630 Pyrus pyrifolia var culta Nutrition 0.000 description 2
- 240000002609 Pyrus pyrifolia var. culta Species 0.000 description 2
- 241000277288 Salmo trutta Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 239000010794 food waste Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 210000002816 gill Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- BITHHVVYSMSWAG-KTKRTIGZSA-N (11Z)-icos-11-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCC(O)=O BITHHVVYSMSWAG-KTKRTIGZSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 1
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical class OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 description 1
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- UXDDRFCJKNROTO-UHFFFAOYSA-N Glycerol 1,2-diacetate Chemical compound CC(=O)OCC(CO)OC(C)=O UXDDRFCJKNROTO-UHFFFAOYSA-N 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000277334 Oncorhynchus Species 0.000 description 1
- 241000277326 Oncorhynchus gorbuscha Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000276618 Perciformes Species 0.000 description 1
- 241000277293 Salvelinus alpinus Species 0.000 description 1
- 241000277284 Salvelinus fontinalis Species 0.000 description 1
- 241001074865 Schizothorax richardsonii Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000026487 Triploidy Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009402 cross-breeding Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229940108623 eicosenoic acid Drugs 0.000 description 1
- BITHHVVYSMSWAG-UHFFFAOYSA-N eicosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCC(O)=O BITHHVVYSMSWAG-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- -1 etc. Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000019844 food fortifying agent Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000005431 greenhouse gas Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000035992 intercellular communication Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000008257 shaving cream Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/22—Animal feeding-stuffs from material of animal origin from fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present invention relates to a method for producing a composition containing exosomes and a composition containing diacylglycerol-containing exosomes.
- Patent Document 1 discloses a technology related to the effective use of seafood processing residue.
- Exosomes are extracellular vesicles with a particle size of approximately 20 nm to approximately 300 nm that are released from various cells, and are used for various purposes including intercellular communication, antigen presentation, and transport of proteins and nucleic acids such as mRNA and miRNA. It is a cellular component known to have various functions. Various health effects have also been reported, and it has attracted attention in recent years.
- Patent Document 2 discloses a cosmetic composition by promoting the secretion of exosomes
- Patent Document 3 discloses a viral infection improving agent containing exosomes.
- exosomes have been attracting attention in recent years, but there are various methods for recovering exosomes from samples, and it is necessary to consider the conditions and methods of recovery depending on the sample and purpose used. Become. Generally, methods such as centrifugation and chromatography are used.
- the problem to be solved by the present invention is to provide a new method for producing a composition containing exosomes and a composition containing diacylglycerol-containing exosomes.
- the present inventors have completed the present invention by discovering that a composition containing exosomes can be produced from fish by treating the fish with water at 40°C or higher.
- the present inventors also discovered that exosomes derived from fish contain diacylglycerol, and completed the present invention.
- the present invention includes the following.
- a method for producing a composition containing exosomes comprising a step of treating fish with water at 40°C or higher.
- the production method according to any one of (1) to (5) which uses one or more parts selected from the body, head, bone, and skin of the fish.
- the manufacturing method according to any one of (1) to (6) wherein the water is physiological saline.
- the process includes the step of treating one or more parts selected from the body, head, bone, and skin of Fujinosuke, which is a hybrid of King Salmon and Rainbow Trout, with water at 50°C or higher. , a method for producing a composition containing exosomes from Fujinosuke.
- the water may be physiological saline.
- a composition comprising a fish-derived diacylglycerol-containing exosome.
- composition according to (9), wherein the content of the diacylglycerol is 4 pmol/10 10 particles or more.
- a method for producing a composition containing exosomes and a composition containing diacylglycerol-containing exosomes can be provided.
- the present invention relates to a method for producing a composition containing exosomes, which includes a step of treating fish with water at 40° C. or higher.
- the process of treating fish with water is not particularly limited, but for example, water may be added to fish, or fish may be added to water. Treating with water at 40°C or higher means that the water is at 40°C or higher when treating fish, and the heated water and fish are heated to 40°C or higher. Alternatively, water and fish may be mixed and heated to 40°C or higher. Furthermore, when treating fish with water at 40° C. or higher, it is preferable to heat the water to an appropriate temperature, preferably 40° C. or higher.
- the process of treating fish with water may be simply referred to as the "main treatment process".
- the time for processing fish is not particularly limited, but may be, for example, 5 minutes or more, 10 minutes or more, 15 minutes or more, 20 minutes or more, 30 minutes or more, 40 minutes or more, 50 minutes or more, and 360 minutes or less. , 300 minutes or less, 240 minutes or less, 200 minutes or less, 180 minutes or less, 120 minutes or less, 60 minutes or less, etc.
- the numerical range may be selected as any combination of an upper limit value (shown below) and a lower limit value (shown above), for example, 20 minutes or more and 240 minutes or less, 20 It may be more than 1 minute and less than 200 minutes.
- the time for processing fish may be 20 minutes or more and 120 minutes or less, 20 minutes or more and 60 minutes or less, 15 minutes or more and 120 minutes or less, and 15 minutes or more and 60 minutes or less.
- the water temperature during the time of treating fish is preferably 40 ° C. or higher during the treatment time, but this does not mean that the water temperature must always be 40 ° C. or higher during the time of treating fish. In this treatment step, there is no restriction on the water temperature being less than 40°C. Note that the fish processing time and water temperature may be appropriately combined within the ranges described in this specification.
- the water used in this treatment step may be pure water, tap water, well water, mineral spring water, mineral water, hot spring water, spring water, fresh water, etc., or water that has been subjected to various treatments.
- Treatments applied to water include, but are not particularly limited to, purification, heating, sterilization, filtration, ion exchange, osmotic pressure adjustment, buffering, and the like. Therefore, the water used in the process of treating fish may be purified water, heated water, ion exchange water, physiological saline, buffer solution, or the like.
- the amount of water used in this treatment step is not particularly limited, but includes, for example, an amount such that all the fish to be treated are submerged in water.
- the ratio may be 1:1 to 1:10, 1:1 to 1:5, 1:1 to 1:4, 1:1 to 1:3.
- the volume of water may be equal to the weight of the fish.
- the temperature of the water used in this treatment step is not particularly limited as long as it is 40°C or higher, but may be, for example, 45°C or higher, 50°C or higher, 55°C or higher, 60°C or higher, etc., 90°C or lower, 85°C or higher, etc. It may be below 80°C, below 75°C, below 70°C, below 65°C, etc.
- the temperature of the water may be 55°C or more and 90°C or less, 55°C or more and 80°C or less, 55°C or more and 75°C or less, 55°C or more and 70°C or less, 55°C or more and 65°C or less, and the like.
- any combination of times for treating the fish may be applied within the temperature range of the water.
- This treatment step may be performed while standing still, may be performed while stirring, or may be performed while pressurizing. This treatment step may be repeated from the viewpoint of increasing purity.
- a liquid (liquid) containing exosomes By treating fish with water and collecting the liquid portion, a liquid (liquid) containing exosomes can be obtained.
- the liquid portion recovered in this treatment step is referred to as "water treatment liquid.”
- Recovery of the liquid portion is not particularly limited, and may be performed, for example, by leaving it still and separating the liquid portion, removing the solid portion, or collecting the supernatant after centrifugation. Conditions for centrifugation treatment may be appropriately set by those skilled in the art.
- filtration treatment may be performed, although not particularly limited. The method of filtration treatment may also be appropriately selected by those skilled in the art.
- This treatment step includes at least a step of mixing water at 40° C. or higher and fish. Exosomes are transferred from fish by treating a mixture of water and fish at a predetermined water temperature.
- This treatment step can also be understood as a type of exosome extraction step. Therefore, this treatment step is not particularly limited, but may include, for example, a step of mixing water at 40° C. or higher with fish, and a step of allowing the resulting mixture to elapse for a predetermined period of time.
- this treatment step includes a step of mixing water with a temperature of 40° C.
- a step of allowing the resulting mixture to elapse at a predetermined water temperature for a predetermined time, and a step of obtaining a water treatment liquid. may also be included.
- the process of obtaining a water treatment liquid can be said to be a process of separating a liquid portion from a mixture from which exosomes are extracted, which is obtained by allowing a predetermined period of time to pass through the resulting mixture.
- the method for producing a composition containing exosomes of the present invention may further include a step of concentrating the water treatment liquid.
- the step of concentrating the water treatment liquid is not particularly limited, but it may be concentrated by, for example, vacuum distillation.
- the method for producing a composition containing exosomes of the present invention may further include a step of purifying a water treatment liquid.
- the method for producing a composition containing exosomes of the present invention may further include a step of washing the sample to be subjected to this treatment step with water and a step of pre-treating the sample.
- a person skilled in the art can appropriately perform the step of washing the sample with water or pre-treating it, but for example, washing with water may be carried out by immersing the sample in running water, or the step of pre-treating the sample by removing scales, internal organs, gills, etc. Processing may be performed.
- there is no particular limitation as long as the sample can be separated into meat, head, bones, and skin in the pretreatment step for example, a method commonly used by those skilled in the art, such as dividing into two pieces or three pieces.
- the method for producing a composition containing exosomes of the present invention includes: If desired, it may include a step of washing the fish or a step of pre-treating the fish (or a step of washing the fish and/or pre-treating the fish), The method includes a step of treating fish with water at 40° C. or higher, and preferably includes a step of treating fish with water at 40° C. or higher for a predetermined time (preferably the above-mentioned time).
- This processing step is A step of mixing water with a temperature of 40°C or higher and fish; A step of allowing the obtained mixture to elapse for a predetermined time at a predetermined water temperature; (Standing, pressurizing, and stirring)
- the method may include a step of obtaining a water treatment liquid.
- the step of obtaining a water treatment liquid may be a step of separating a liquid portion from a mixture from which exosomes are extracted after a predetermined period of time, and preferably a step of obtaining a liquid portion by solid-liquid separation. There may be.
- fish examples include teleost fishes, cartilaginous fishes, etc., but preferably teleost fishes.
- fish refers to not only the entire fish body, but also parts of the fish body, such as its tissues and organs.
- the fish may be natural fish or farmed fish.
- Examples of the teleost fishes include Salmonidae, Herringidae, Orientalidae, Acanthidae, Amaranthidae, Salmonidae, Salmonidae, Codidae, Mulletae, Perciformes, Pufferidae, Eelidae, etc., but Salmonidae is preferable. .
- the family Salmonidae is known.
- fish of the family Salmonidae means fish belonging to the order Salmonidae.
- Known members of the family Salmonidae include the subfamily Salmonidae, the subfamily Salmonidae, and the subfamily Salmonidae.
- Examples of the subfamily Salmonidae include the genus Salmon (also referred to as the genus Atlantic Salmon and the genus Oncorhynchus), the genus Atlantic Salmon, the genus Char, the genus Itu, and the genus Smallmouth.
- Examples of the salmon genus include Masunosuke (king salmon), chum salmon, coho salmon, sockeye salmon, rainbow trout, cherry salmon, loquat trout, kunimasu, pink salmon, and the like.
- Examples of the Atlantic salmon genus include Atlantic salmon, brown trout, and the like.
- Examples of the genus Char include Amemasu trout, Oshorokoma, Miyabeiwana, Brook trout, Char, and the like.
- Examples of the genus Ito include Ito.
- Examples of the genus Smallmouth include Smallmouth trout, Gaimamus, Amur trout, and the like.
- the genus Shiromasu is known as the subfamily Shiromasu.
- Examples of the genus Whitefish include whitefish, whitefish, and whitefish.
- the genus Kawahimemasu is known as the subfamily Kawahimemasu.
- Examples of the genus Kawahimemasu include Kitakawahimemasu, Honkawahimemasu, and the like.
- Typical species of salmonids include, for example, king salmon, chum salmon, sockeye salmon, coho salmon, rainbow trout, pink trout, cherry salmon, Atlantic salmon, brown trout, itou, Amur itou, char, Examples include Oshorokoma, Arctic char, Omuri, and Shinano snow trout.
- preference is given to salmon salmon (king salmon), chum salmon, coho salmon, sockeye salmon, rainbow trout, cherry salmon, loquat trout, kunimasu, pink trout, char, and yamame, and more preferable are salmon salmon and rainbow trout.
- a hybrid species of fish may be used.
- the hybrid species may be a hybrid between the same species or a hybrid between different species.
- the hybrid is preferably an interspecific hybrid.
- the hybrid species is preferably an interspecies hybrid of salmonid fish, more preferably a hybrid of Japanese trout and rainbow trout. Crossbreeding of fish can be carried out appropriately by those skilled in the art using known techniques. Commercially available hybrid fish may also be used.
- Fujinosuke is a hybrid of Masunosuke (king salmon) and rainbow trout developed by the Yamanashi Prefectural Fisheries Technology Center. Concerning the seed production and aquaculture methods of Fujinosuke, the Fisheries Agency completed confirmation in 2016 based on the ⁇ Guidelines for the Use of Aquatic Products such as Triploid Fish,'' and aquaculture began in 2017. At the Yamanashi Prefectural Fisheries Technology Center, we manage and raise Fujinosuke by setting standards for production, rearing with prepared feed, and methods for preserving meat color and freshness at the time of shipment. Fujinosuke is a cross-species salmonid species that combines the deliciousness of king salmon with the ease of raising rainbow trout.
- the head of a fish is defined as the length from the tip of the mouth separated from the fish body to the rear end of the bone covering the gills (opercular bone).
- the bones of fish refer to the middle bones, abdominal bones, blood bones, small bones, etc. that are separated from the fish body, and the skin parts of fish refer to the epidermis and dermis that are separated or stripped from the fish body. It may also include scales.
- the fish body refers to the fish meat that is left after separating the head, bones, and skin from the fish body. The body may be attached to the head, bones, and skin of the fish, and the head, bones, and skin may be attached to the body of the fish.
- the present invention also relates to a composition containing exosomes produced by the method for producing a composition containing exosomes of the present invention.
- a composition containing exosomes produced by the production method of the present invention contains exosomes. Confirmation that exosomes are included can be performed using, for example, a nanoparticle analysis system (Nanosite LM10, Nippon Quantum Design Co., Ltd.), although there are no particular limitations.
- the amount of exosomes contained in the exosome-containing composition produced by the production method of the present invention is not particularly limited, but for example, the number of particles is 2.0 ⁇ 10 9 /mL or more, 5.0 ⁇ 10 9 1.0 x 10 10 pieces/mL or more, 4.0 x 10 10 pieces/mL or more, 5.0 x 10 10 pieces/mL or more, 6.0 x 10 10 pieces/mL or more, 7 It may be .0 ⁇ 10 10 pieces/mL or more, 8.0 ⁇ 10 10 pieces/mL or more, etc.
- the amount of exosomes contained in the exosome-containing composition produced by the production method of the present invention is not particularly limited, but the number of particles per weight of fish is 8.0 ⁇ 10 9 particles / g or more, 9.0 The number may be at least ⁇ 10 9 pieces/g, 1.0 ⁇ 10 10 pieces/g or more, 1.1 ⁇ 10 10 pieces/g or more, 1.2 ⁇ 10 10 pieces/g or more, etc.
- the particle size of the exosomes contained in the exosome-containing composition produced by the production method of the present invention is not particularly limited, but for example, the average diameter is 20 nm or more, 50 nm or more, 100 nm or more, 120 nm or more, 150 nm or more, 160 nm. The above may be the case.
- the average diameter may be 300 nm or less and 200 nm or less.
- the average diameter of exosomes may be 20 nm or more and 300 nm or less, and within this range, the average diameter may be set to the above upper limit or lower limit as appropriate.
- the average diameter of exosomes may be 100 nm or more and 200 nm or less.
- the number of particles as the amount of exosomes and the average diameter of exosomes can be measured as analysis results using a nanoparticle analysis system, as described in Examples.
- composition containing exosomes produced by the production method of the present invention may also contain other water-soluble components eluted by the process of treating fish with water.
- Such other water-soluble components include, but are not particularly limited to, collagen, gelatin, vitamins, fatty acids, amino acids, polysaccharides, peptides, and the like. These water-soluble components may be derived from fish.
- the present invention also relates to compositions comprising diacylglycerol-containing exosomes derived from fish.
- the composition contains diacylglycerol-containing exosomes derived from fish, and in diacylglycerol-containing exosomes, the exosomes contain diacylglycerol, and the exosomes and diacylglycerol are, for example, separated into one liquid. It does not mean that it exists inside. Note that as long as the exosome contains diacylglycerol, the diacylglycerol-containing exosome and diacylglycerol may be present separately in one liquid.
- Diacylglycerol-containing exosomes derived from fish may contain diacylglycerol as a membrane component of the exosome, or may contain diacylglycerol within the vesicles of the exosome.
- DAG Diacylglycerol
- DAG is a molecule in which two fatty acids are bonded to glycerin via an ester bond, and has attracted attention for its various physiological effects. Therefore, the composition of the present invention containing fish-derived diacylglycerol-containing exosomes is a composition that can be expected to have not only physiological effects due to exosomes but also physiological effects due to diacylglycerol.
- the content of diacylglycerol in exosomes may be 3 pmol / 10 particles or more, 4 pmol/10 particles or more, 4.5 pmol/ 10 particles or more, or 5 pmol/10 particles or more.
- the amount may be 10 10 particles or more, 5.5 pmol/10 10 particles or more, 6 pmol/10 10 particles or more, or 6.5 pmol/10 10 particles or more.
- the content of diacylglycerol in the exosomes may be 9 pmol/ 10 particles or less, 8 pmol/ 10 particles or less, 7.5 pmol/ 10 particles or less, The amount may be 7 pmol/10 10 particles or less.
- the content of diacylglycerol in exosomes is within any of the above ranges, for example, 4 pmol/10 10 particles or more and 8 pmol/10 10 particles or less, 4.5 pmol/ 10 10 particles or more and 8 pmol/ 10 10 particles or less, 5.
- the amount may be 5 pmol/ 10 10 particles or more and 7 pmol/ 10 10 particles or less.
- the content of diacylglycerol in exosomes can be measured as an analysis result using a DAG (diacylglycerol) assay kit, as described in the Examples.
- the content of diacylglycerol in exosomes was determined by analysis using an exosome solution obtained by diluting a composition containing exosomes with a solution such as PBS or a solvent (or water used in this treatment step). It may be a value measured as .
- Diacylglycerol consists of 1,2-diacyl glycerol (1,2-DAG), in which fatty acids are bound to the 1st and 2nd positions of glycerin, and 1,3-diacylglycerol (1,3-DAG), in which fatty acids are bound to the 1st and 3rd positions of glycerin.
- DAG may be any structure.
- the fatty acids constituting diacylglycerol may be saturated fatty acids, unsaturated fatty acids, both saturated fatty acids and unsaturated fatty acids, or either one.
- the unsaturated fatty acids may be ⁇ -3 (n-3) fatty acids, ⁇ -6 (n-6) fatty acids, ⁇ -9 (n-9) fatty acids, A combination of these may also be used.
- the number of double bonds in the unsaturated fatty acid is about 1 to 6 and is not particularly limited.
- the number of carbon atoms in the fatty acid is about 2 or more and 22 or less, and may be, for example, 2 or more, 4 or more, 16 or more, 18 or more, or 22 or less, 20 or less, 18 or less.
- the number of carbon atoms in the fatty acid may be within the above range, for example, 18 or more and 22 or less, 18 or more and 20 or less.
- Examples of fatty acids constituting diacylglycerol include acetic acid, butyric acid, palmitic acid, stearic acid, oleic acid, linoleic acid, ⁇ -linolenic acid, ⁇ -linolenic acid, dihomo- ⁇ -linolenic acid, arachidonic acid, eicosenoic acid, Examples include eicosapentaenoic acid (EPA), docosapentaenoic acid, docosahexaenoic acid (DHA), and the like.
- EPA eicosapentaenoic acid
- DHA docosahexaenoic acid
- fatty acids having 18 or 20 carbon atoms are preferable, and the content of diacylglycerol in exosomes is the content of diacylglycerol to which at least one fatty acid having 18 or 20 carbon atoms is bonded in exosomes. It may be the content of diacylglycerol in which two fatty acids having 18 or 20 carbon atoms are bonded in the exosome.
- composition containing diacylglycerol-containing exosomes derived from fish of the present invention may be produced by isolating exosomes from fish using methods well known to those skilled in the art as methods for isolating exosomes.
- a composition containing fish-derived diacylglycerol-containing exosomes may be produced by the production method of the present invention. That is, exosomes contained in a composition containing exosomes produced by a method for producing a composition containing exosomes, which includes a step of treating fish with water at 40° C. or higher, may contain diacylglycerol.
- the composition containing exosomes of the present invention may be a composition containing exosomes produced by a method for producing a composition containing exosomes, which includes a step of treating fish with water at 40°C or higher, and may be a composition containing exosomes produced from a fish-derived composition.
- the composition may include a diacylglycerol-containing exosome.
- Such compositions may include any other components in addition to exosomes.
- Optional other components can be appropriately determined by those skilled in the art depending on the form and purpose of the composition, and may include, for example, collagen, gelatin, vitamins, fatty acids, amino acids, polysaccharides, peptides, etc.
- composition containing exosomes may be a component that can be eluted by the process of treating fish with water, that is, a component derived from fish, or may be an added component.
- the composition containing exosomes may also contain additives commonly used in the uses described below.
- the composition containing exosomes may contain components for promoting the internalization of exosomes and cell targeting effects, buffer components, physiological saline, etc., and other active ingredients used in the following applications. May contain.
- the composition containing the exosome of the present invention can be used as an oral preparation or an external preparation.
- the composition containing exosomes of the present invention may be used as is, or the exosomes may be concentrated or extracted.
- the composition containing exosomes of the present invention can be used in supplements, multivitamin preparations, multivitamin preparations, amino acid preparations, nourishing and tonic altering agents, chondroitin preparations, food fortifying agents, organ preparations, protein and amino acid preparations, cosmetics for anti-wrinkle packs, cold It may be used as a cream, hand cream, shaving cream, foundation cream, medicated cream, hair cosmetic, setting lotion, hair cream, bath oil, bath salt, baby oil, baby powder, etc.
- composition containing the exosome of the present invention may be used as a food, a cosmetic, or a pharmaceutical.
- the target is preferably humans, but it may also be used for pets as pet food, supplementary food for pets, and supplements for pets.
- Oral preparations, external preparations, and preparations for various uses are not particularly limited, and can be prepared according to conventionally known methods.
- composition containing fish-derived diacylglycerol-containing exosomes of the present invention can be used, for example, in addition to general foods, foods with health functions such as foods for specified health uses, foods with nutritional function claims, and foods with functional claims that claim the physiological effects of diacylglycerol and exosomes. It may be used in foods, health foods (including foods labeled as nutritional supplements, health supplements, nutritional adjustment foods, etc.), supplements, and the like.
- composition containing fish-derived diacylglycerol-containing exosomes of the present invention include, for example, reducing fasting neutral fat, postprandial Suppressing the rise in blood triglycerides, lowering LDL cholesterol, reducing body mass index (BMI), suppressing body fat accumulation in obese people, reducing body fat, risk of lifestyle-related diseases It may also be used for the purpose of promoting health, such as reducing.
- BMI body mass index
- the usefulness of the composition containing diacylglycerol-containing exosomes derived from fish of the present invention is that the exosomes are absorbed into the body without being degraded in the gastrointestinal tract, are transported to the liver and other organs, and release the diacylglycerol content. It is also believed that diacylglycerol acts in the liver and other organs.
- Three Fujinosuke pieces were processed and separated into a first part (head, bone, and skin) and a second part (body). 200 g of the second portion was blended and 600 mL of water (approximately 3 times the amount) was added. After filtering through a sieve, centrifugation was performed. The floating oil could not be successfully separated, and exosomes were not obtained.
- Three Fujinosuke pieces were processed and separated into a first part (head, bone, and skin) and a second part (body). 2.1 kg of the second part was cut into pieces, and 5000 mL of water (approximately 2.5 times the amount) was added. The mixture was heated at 90° C. for 30 minutes, left to stand, and a floating oil was obtained. After suction filtration, the mixture was centrifuged (3500 rpm). Although it was not possible to confirm the presence of exosomes in the floating oil, when PBS was added to the floating oil, the presence of exosomes was confirmed.
- Three Fujinosuke pieces were processed and separated into a first part (head, bone, and skin) and a second part (body). 1000 mL (approximately twice the volume) of physiological saline was added to 500 g of each of the first site and the second site. The mixture was heated at 60° C. for 3 hours and subjected to solid-liquid separation by filter paper filtration to obtain each composition containing exosomes.
- Three Fujinosuke pieces were processed and separated into a first part (bone part and skin part) and a second part (body part).
- 600 mL (approximately twice the volume) of physiological saline was added to 300 g of each of the first site and the second site.
- the mixture was heated at 40° C. or 60° C. for 30 minutes, and subjected to filter paper filtration for solid-liquid separation to obtain exosome-containing compositions. Although heating at 40° C. for 3 hours was attempted, there was a possibility of spoilage, so production of the composition containing exosomes was discontinued.
- the processing temperature was set to 60°C
- the number of general viable bacteria was 0 in the microbial test, and the results were negative for coliform bacteria, E. coli, and Staphylococcus aureus; however, when the processing temperature was set to 40°C
- the number of viable bacteria was 3.0 to 3.8 ⁇ 10 2 . It is preferable to carry out the treatment at a temperature of 60° C. or higher from the viewpoint of removing bacteria and viruses.
- Each microbial test was performed using the following method.
- Adipose mesenchymal stem cell exosomes (adipose mesenchymal stem cell EVs) were used as a control. The results are shown in Figure 1.
- "Fujinosuke EVs” means exosomes obtained using the first site (bone and skin).
- Aomori Kurenai salmon Three pieces of fish were processed and separated into a first part (head, bone, and skin) and a second part (body). 600 mL (approximately twice the volume) of physiological saline was added to 300 g of each of the first site and the second site. The mixture was heated at 60° C. for 30 minutes and subjected to solid-liquid separation by filter paper filtration to obtain each composition containing exosomes. In addition, in the microbiological test, the general viable bacteria count was 0, and the results were negative for coliform bacteria, Escherichia coli, and Staphylococcus aureus.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Birds (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Child & Adolescent Psychology (AREA)
- Fodder In General (AREA)
- Meat, Egg Or Seafood Products (AREA)
Abstract
The present invention relates to a method for producing a composition comprising an exosome, the method including a step for treating fish with water at 40 °C or higher. In addition, the present invention relates to a composition comprising a fish-derived diacylglycerol-containing exosome.
Description
本発明は、エクソソームを含む組成物の製造方法及びジアシルグリセロール含有エクソソームを含む組成物に関する。
The present invention relates to a method for producing a composition containing exosomes and a composition containing diacylglycerol-containing exosomes.
近年、わが国における魚類の消費量は減少を続けていることが報告されている。一方、種類別にみると、魚類消費量におけるサケ科の魚類が占める割合は上昇傾向にあることが報告されている。これらの傾向の背景には、調理の簡易化志向の高まりによる、調理しやすい形態で購入できる魚種の需要の高まりがある(参考資料として、令和3年度 水産白書 水産庁がある。)。
It has been reported that the consumption of fish in Japan has continued to decline in recent years. On the other hand, by type, it has been reported that the proportion of salmonid fish in fish consumption is on the rise. Behind these trends is a growing demand for fish species that can be purchased in easy-to-cook formats due to a growing preference for simpler cooking (reference materials include the 2021 Fisheries White Paper, Fisheries Agency).
調理の簡易化志向により、調理しやすい形態で市場に売り出されることが増えた結果、魚体の多くの部分を水産加工残渣として廃棄するケースが増加していることが考えられる。しかしながら、水産加工残渣をはじめとする食品廃棄物は温室効果ガスの発生等、環境に悪影響を及ぼすこと等から削減の必要性が叫ばれており、先進国にとっても途上国にとっても喫緊の課題となっている。
As a result of the trend toward simpler cooking, more and more fish are sold in easy-to-cook formats, and as a result, it is thought that there is an increase in the number of cases in which large parts of fish bodies are discarded as seafood processing residue. However, there is a growing need to reduce food waste, including residues from seafood processing, as it has a negative impact on the environment, including the generation of greenhouse gases, and is an urgent issue for both developed and developing countries. It has become.
魚類は優れた栄養性や様々な機能性を有することが報告されているが、上記のような食品廃棄物の削減の観点からは、さらなる機能性の探究のニーズがあり、従来食用に用いられずに廃棄されることの多かった部位における機能性の探究はさらに求められる。例えば、特許文献1には、水産加工残渣の有効利用に関する技術が開示されている。
It has been reported that fish have excellent nutritional properties and a variety of functionalities, but from the perspective of reducing food waste as mentioned above, there is a need to explore further functionality. There is a need to further explore the functionality of parts that are often discarded. For example, Patent Document 1 discloses a technology related to the effective use of seafood processing residue.
また、近年、「エクソソーム」と呼ばれる細胞外小胞に注目が集まり、エクソソームの機能等についての研究が加速度的に増加している。中でも、2021年より、日本では、「エクソソームを含む細胞外小胞(EV)を利用した治療用製剤に関する専門部会」が開催され、エクソソームを含む細胞外小胞(EV)を利用した治療用製剤に関する検討がなされている。また、日本再生医療学会も、2021年に、「エクソソーム等の調製・治療に対する考え方」を発表している。
In addition, in recent years, extracellular vesicles called "exosomes" have attracted attention, and research on the functions of exosomes has been increasing at an accelerating pace. In particular, from 2021, in Japan, the ``Special Committee on Therapeutic Preparations Using Extracellular Vesicles (EVs) Containing Exosomes'' will be held, and will Considerations are being made regarding this. In addition, the Japanese Society for Regenerative Medicine has also announced in 2021, "Thoughts on the preparation and treatment of exosomes, etc."
「エクソソーム」とは、様々な細胞から放出される粒子径約20nm~約300nmの細胞外小胞であり、細胞間通信、抗原提示、タンパク質並びにmRNA及びmiRNA等の核酸の輸送をはじめとする様々な機能を有することが知られている細胞成分である。様々な健康作用も報告されており、近年注目されている。例えば、特許文献2には、エクソソームの分泌を促進することによる美容組成物が開示されており、特許文献3には、エクソソームを含むウイルス感染症改善剤が開示されている。
"Exosomes" are extracellular vesicles with a particle size of approximately 20 nm to approximately 300 nm that are released from various cells, and are used for various purposes including intercellular communication, antigen presentation, and transport of proteins and nucleic acids such as mRNA and miRNA. It is a cellular component known to have various functions. Various health effects have also been reported, and it has attracted attention in recent years. For example, Patent Document 2 discloses a cosmetic composition by promoting the secretion of exosomes, and Patent Document 3 discloses a viral infection improving agent containing exosomes.
上述のとおり近年注目されているエクソソームであるが、試料からエクソソームを回収する手段としては多様な方法が存在しており、用いる試料や目的に応じた回収の条件や方法を検討することが必要となる。一般には、遠心処理やクロマトグラフィー等の方法が用いられている。
As mentioned above, exosomes have been attracting attention in recent years, but there are various methods for recovering exosomes from samples, and it is necessary to consider the conditions and methods of recovery depending on the sample and purpose used. Become. Generally, methods such as centrifugation and chromatography are used.
本発明が解決しようとする課題は、エクソソームを含む組成物の新たな製造方法及びジアシルグリセロール含有エクソソームを含む組成物を提供することである。
The problem to be solved by the present invention is to provide a new method for producing a composition containing exosomes and a composition containing diacylglycerol-containing exosomes.
本発明者らが鋭意検討した結果、40℃以上の水で魚類を処理することにより、魚類からエクソソームを含む組成物を製造することができることを見出し、本発明を完成した。また、本発明者らは、魚類に由来するエクソソームがジアシルグリセロールを含有することを見出し、本発明を完成した。
As a result of intensive studies, the present inventors have completed the present invention by discovering that a composition containing exosomes can be produced from fish by treating the fish with water at 40°C or higher. The present inventors also discovered that exosomes derived from fish contain diacylglycerol, and completed the present invention.
すなわち、本発明は、以下を包含する。
(1)
40℃以上の水で魚類を処理する工程を含む、エクソソームを含む組成物の製造方法。
(2)
50℃以上70℃以下で処理する、(1)に記載の製造方法。
(3)
前記魚類が、サケ科の魚類である、(1)又は(2)に記載の製造方法。
(4)
前記魚類が、マスノスケ(キングサーモン)、シロザケ、ギンザケ、ベニザケ、ニジマス、サクラマス、ビワマス、クニマス、カラフトマス、イワナ、ヤマメ又はこれらの交配種である、(1)又は(2)に記載の製造方法。
(5)
前記魚類が、マスノスケ(キングサーモン)及びニジマスの交配種である、(1)又は(2)に記載の製造方法。
(6)
前記魚類の、身部、頭部、骨部及び皮部から選択される1つ以上の部位を用いる、(1)~(5)のいずれかに記載の製造方法。
(7)
前記水が、生理食塩水である、(1)~(6)のいずれかに記載の製造方法。
(8)
50℃以上の水で、マスノスケ(キングサーモン)及びニジマスの交配種である富士の介の、身部、頭部、骨部及び皮部から選択される1つ以上の部位を処理する工程を含む、富士の介からエクソソームを含む組成物を製造する方法。前記水は、生理食塩水であってよい。
(9)
魚類由来のジアシルグリセロール含有エクソソームを含む、組成物。
(10)
前記ジアシルグリセロールの含有量が、4pmol/1010粒子以上である、(9)に記載の組成物。
(11)
前記ジアシルグリセロールが、炭素数18以上20以下の脂肪酸からなる群から選択される脂肪酸に由来する構造を有する、(9)に記載の組成物。 That is, the present invention includes the following.
(1)
A method for producing a composition containing exosomes, comprising a step of treating fish with water at 40°C or higher.
(2)
The manufacturing method according to (1), wherein the process is performed at a temperature of 50°C or higher and 70°C or lower.
(3)
The manufacturing method according to (1) or (2), wherein the fish is a salmonid fish.
(4)
The production method according to (1) or (2), wherein the fish is King Salmon, Chum Salmon, Coho Salmon, Sockeye Salmon, Rainbow Trout, Sakura Salmon, Biwa Salmon, Kunimasu, Pink Salmon, Char, Yamame, or a hybrid thereof.
(5)
The production method according to (1) or (2), wherein the fish is a hybrid of King Salmon and Rainbow Trout.
(6)
The production method according to any one of (1) to (5), which uses one or more parts selected from the body, head, bone, and skin of the fish.
(7)
The manufacturing method according to any one of (1) to (6), wherein the water is physiological saline.
(8)
The process includes the step of treating one or more parts selected from the body, head, bone, and skin of Fujinosuke, which is a hybrid of King Salmon and Rainbow Trout, with water at 50°C or higher. , a method for producing a composition containing exosomes from Fujinosuke. The water may be physiological saline.
(9)
A composition comprising a fish-derived diacylglycerol-containing exosome.
(10)
The composition according to (9), wherein the content of the diacylglycerol is 4 pmol/10 10 particles or more.
(11)
The composition according to (9), wherein the diacylglycerol has a structure derived from a fatty acid selected from the group consisting of fatty acids having 18 or more and 20 or less carbon atoms.
(1)
40℃以上の水で魚類を処理する工程を含む、エクソソームを含む組成物の製造方法。
(2)
50℃以上70℃以下で処理する、(1)に記載の製造方法。
(3)
前記魚類が、サケ科の魚類である、(1)又は(2)に記載の製造方法。
(4)
前記魚類が、マスノスケ(キングサーモン)、シロザケ、ギンザケ、ベニザケ、ニジマス、サクラマス、ビワマス、クニマス、カラフトマス、イワナ、ヤマメ又はこれらの交配種である、(1)又は(2)に記載の製造方法。
(5)
前記魚類が、マスノスケ(キングサーモン)及びニジマスの交配種である、(1)又は(2)に記載の製造方法。
(6)
前記魚類の、身部、頭部、骨部及び皮部から選択される1つ以上の部位を用いる、(1)~(5)のいずれかに記載の製造方法。
(7)
前記水が、生理食塩水である、(1)~(6)のいずれかに記載の製造方法。
(8)
50℃以上の水で、マスノスケ(キングサーモン)及びニジマスの交配種である富士の介の、身部、頭部、骨部及び皮部から選択される1つ以上の部位を処理する工程を含む、富士の介からエクソソームを含む組成物を製造する方法。前記水は、生理食塩水であってよい。
(9)
魚類由来のジアシルグリセロール含有エクソソームを含む、組成物。
(10)
前記ジアシルグリセロールの含有量が、4pmol/1010粒子以上である、(9)に記載の組成物。
(11)
前記ジアシルグリセロールが、炭素数18以上20以下の脂肪酸からなる群から選択される脂肪酸に由来する構造を有する、(9)に記載の組成物。 That is, the present invention includes the following.
(1)
A method for producing a composition containing exosomes, comprising a step of treating fish with water at 40°C or higher.
(2)
The manufacturing method according to (1), wherein the process is performed at a temperature of 50°C or higher and 70°C or lower.
(3)
The manufacturing method according to (1) or (2), wherein the fish is a salmonid fish.
(4)
The production method according to (1) or (2), wherein the fish is King Salmon, Chum Salmon, Coho Salmon, Sockeye Salmon, Rainbow Trout, Sakura Salmon, Biwa Salmon, Kunimasu, Pink Salmon, Char, Yamame, or a hybrid thereof.
(5)
The production method according to (1) or (2), wherein the fish is a hybrid of King Salmon and Rainbow Trout.
(6)
The production method according to any one of (1) to (5), which uses one or more parts selected from the body, head, bone, and skin of the fish.
(7)
The manufacturing method according to any one of (1) to (6), wherein the water is physiological saline.
(8)
The process includes the step of treating one or more parts selected from the body, head, bone, and skin of Fujinosuke, which is a hybrid of King Salmon and Rainbow Trout, with water at 50°C or higher. , a method for producing a composition containing exosomes from Fujinosuke. The water may be physiological saline.
(9)
A composition comprising a fish-derived diacylglycerol-containing exosome.
(10)
The composition according to (9), wherein the content of the diacylglycerol is 4 pmol/10 10 particles or more.
(11)
The composition according to (9), wherein the diacylglycerol has a structure derived from a fatty acid selected from the group consisting of fatty acids having 18 or more and 20 or less carbon atoms.
本発明によれば、エクソソームを含む組成物を製造する方法及びジアシルグリセロール含有エクソソームを含む組成物を提供することができる。
According to the present invention, a method for producing a composition containing exosomes and a composition containing diacylglycerol-containing exosomes can be provided.
以下、本発明を実施するための形態について詳細に説明する。なお、本発明は以下の実施形態に限定されるものではなく、その要旨の範囲内で種々変形して実施することができる。
Hereinafter, modes for carrying out the present invention will be described in detail. Note that the present invention is not limited to the following embodiments, and can be implemented with various modifications within the scope of the gist.
本発明は、エクソソームを含む組成物の製造方法に関し、40℃以上の水で魚類を処理する工程を含む方法である。
水で魚類を処理する工程は、特に限定されないが、例えば、魚類に水を添加してもよく、水に魚類を添加してもよい。
40℃以上の水で処理するとは、魚類を処理する際に、水が、40℃以上であることを意味し、水を40℃以上に加温して、当該加温された水と、魚類とを混合してもよく、水と魚類を混合して、40℃以上に加温してもよい。
また、40℃以上の水で、魚類を処理する際には、水温を適温、好ましくは、40℃以上となるように、加温しながら、処理することが好ましい。
以下、水で魚類を処理する工程を、単に「本処理工程」という場合がある。 The present invention relates to a method for producing a composition containing exosomes, which includes a step of treating fish with water at 40° C. or higher.
The process of treating fish with water is not particularly limited, but for example, water may be added to fish, or fish may be added to water.
Treating with water at 40°C or higher means that the water is at 40°C or higher when treating fish, and the heated water and fish are heated to 40°C or higher. Alternatively, water and fish may be mixed and heated to 40°C or higher.
Furthermore, when treating fish with water at 40° C. or higher, it is preferable to heat the water to an appropriate temperature, preferably 40° C. or higher.
Hereinafter, the process of treating fish with water may be simply referred to as the "main treatment process".
水で魚類を処理する工程は、特に限定されないが、例えば、魚類に水を添加してもよく、水に魚類を添加してもよい。
40℃以上の水で処理するとは、魚類を処理する際に、水が、40℃以上であることを意味し、水を40℃以上に加温して、当該加温された水と、魚類とを混合してもよく、水と魚類を混合して、40℃以上に加温してもよい。
また、40℃以上の水で、魚類を処理する際には、水温を適温、好ましくは、40℃以上となるように、加温しながら、処理することが好ましい。
以下、水で魚類を処理する工程を、単に「本処理工程」という場合がある。 The present invention relates to a method for producing a composition containing exosomes, which includes a step of treating fish with water at 40° C. or higher.
The process of treating fish with water is not particularly limited, but for example, water may be added to fish, or fish may be added to water.
Treating with water at 40°C or higher means that the water is at 40°C or higher when treating fish, and the heated water and fish are heated to 40°C or higher. Alternatively, water and fish may be mixed and heated to 40°C or higher.
Furthermore, when treating fish with water at 40° C. or higher, it is preferable to heat the water to an appropriate temperature, preferably 40° C. or higher.
Hereinafter, the process of treating fish with water may be simply referred to as the "main treatment process".
魚類を処理する時間は、特に限定されないが、例えば、5分以上、10分以上、15分以上、20分以上、30分以上、40分以上、50分以上等であってよく、360分以下、300分以下、240分以下、200分以下、180分以下、120分以下、60分以下等であってよい。
本明細書においては、数値範囲として、上限値(以下で示す)と下限値(以上で示す)との任意の組み合わせの範囲として選択してもよいが、例えば、20分以上240分以下、20分以上200分以下であってよい。
また、魚類を処理する時間は、20分以上120分以下であってもよく、20分以上60分以下であってもよく、15分以上120分以下であってもよく、15分以上60分以下であってもよい。
魚類を処理する時間における水温は、処理時間中、40℃以上の水温であることが好ましいが、魚類を処理している時間中で、常に40℃以上の水温でなければならないということではなく、本処理工程において、40℃未満の水温となることを妨げるものではない。なお、魚類の処理時間と、水温は、本明細書において記載の範囲内で適宜組み合させてよい。 The time for processing fish is not particularly limited, but may be, for example, 5 minutes or more, 10 minutes or more, 15 minutes or more, 20 minutes or more, 30 minutes or more, 40 minutes or more, 50 minutes or more, and 360 minutes or less. , 300 minutes or less, 240 minutes or less, 200 minutes or less, 180 minutes or less, 120 minutes or less, 60 minutes or less, etc.
In this specification, the numerical range may be selected as any combination of an upper limit value (shown below) and a lower limit value (shown above), for example, 20 minutes or more and 240 minutes or less, 20 It may be more than 1 minute and less than 200 minutes.
Further, the time for processing fish may be 20 minutes or more and 120 minutes or less, 20 minutes or more and 60 minutes or less, 15 minutes or more and 120 minutes or less, and 15 minutes or more and 60 minutes or less. The following may be sufficient.
The water temperature during the time of treating fish is preferably 40 ° C. or higher during the treatment time, but this does not mean that the water temperature must always be 40 ° C. or higher during the time of treating fish. In this treatment step, there is no restriction on the water temperature being less than 40°C. Note that the fish processing time and water temperature may be appropriately combined within the ranges described in this specification.
本明細書においては、数値範囲として、上限値(以下で示す)と下限値(以上で示す)との任意の組み合わせの範囲として選択してもよいが、例えば、20分以上240分以下、20分以上200分以下であってよい。
また、魚類を処理する時間は、20分以上120分以下であってもよく、20分以上60分以下であってもよく、15分以上120分以下であってもよく、15分以上60分以下であってもよい。
魚類を処理する時間における水温は、処理時間中、40℃以上の水温であることが好ましいが、魚類を処理している時間中で、常に40℃以上の水温でなければならないということではなく、本処理工程において、40℃未満の水温となることを妨げるものではない。なお、魚類の処理時間と、水温は、本明細書において記載の範囲内で適宜組み合させてよい。 The time for processing fish is not particularly limited, but may be, for example, 5 minutes or more, 10 minutes or more, 15 minutes or more, 20 minutes or more, 30 minutes or more, 40 minutes or more, 50 minutes or more, and 360 minutes or less. , 300 minutes or less, 240 minutes or less, 200 minutes or less, 180 minutes or less, 120 minutes or less, 60 minutes or less, etc.
In this specification, the numerical range may be selected as any combination of an upper limit value (shown below) and a lower limit value (shown above), for example, 20 minutes or more and 240 minutes or less, 20 It may be more than 1 minute and less than 200 minutes.
Further, the time for processing fish may be 20 minutes or more and 120 minutes or less, 20 minutes or more and 60 minutes or less, 15 minutes or more and 120 minutes or less, and 15 minutes or more and 60 minutes or less. The following may be sufficient.
The water temperature during the time of treating fish is preferably 40 ° C. or higher during the treatment time, but this does not mean that the water temperature must always be 40 ° C. or higher during the time of treating fish. In this treatment step, there is no restriction on the water temperature being less than 40°C. Note that the fish processing time and water temperature may be appropriately combined within the ranges described in this specification.
本処理工程において用いられる水としては、純水、水道水、井戸水、鉱泉水、鉱水、温泉水、湧水、淡水等、又はこれらに各種処理を施したものであってもよい。水に施す処理としては、特に限定されないが、例えば、精製、加温、殺菌、ろ過、イオン交換、浸透圧の調整、緩衝化等が含まれる。よって、魚類を処理する工程において用いられる水としては、精製水、加温処理水、イオン交換水、生理食塩水、緩衝液等であってもよい。
The water used in this treatment step may be pure water, tap water, well water, mineral spring water, mineral water, hot spring water, spring water, fresh water, etc., or water that has been subjected to various treatments. Treatments applied to water include, but are not particularly limited to, purification, heating, sterilization, filtration, ion exchange, osmotic pressure adjustment, buffering, and the like. Therefore, the water used in the process of treating fish may be purified water, heated water, ion exchange water, physiological saline, buffer solution, or the like.
本処理工程において用いられる水の量は、特に限定されないが、例えば、処理に供する魚類が全て水に浸かる程度の量等が挙げられる。例えば、魚類の重量に対する水の容量の比率で、魚類の重量:水の容量=1:1~1:20等の範囲内で適宜設定してもよい。1:1~1:10であってよく、1:1~1:5であってよく、1:1~1:4、1:1~1:3であってもよい。1:1の場合、魚類の重量に対して、水を等倍量の容量で用いればよい。
The amount of water used in this treatment step is not particularly limited, but includes, for example, an amount such that all the fish to be treated are submerged in water. For example, the ratio of the volume of water to the weight of fish may be set as appropriate within a range such as weight of fish: volume of water = 1:1 to 1:20. The ratio may be 1:1 to 1:10, 1:1 to 1:5, 1:1 to 1:4, 1:1 to 1:3. In the case of 1:1, the volume of water may be equal to the weight of the fish.
本処理工程において用いられる水の温度は、40℃以上であれば特に限定されないが、例えば、45℃以上、50℃以上、55℃以上、60℃以上等であってよく、90℃以下、85℃以下、80℃以下、75℃以下、70℃以下、65℃以下等であってよい。例えば、40℃以上90℃以下、40℃以上80℃以下、40℃以上75℃以下、40℃以上70℃以下、50℃以上90℃以下、50℃以上80℃以下、50℃以上75℃以下、50℃以上70℃以下等であってよい。水の温度は、55℃以上90℃以下、55℃以上80℃以下、55℃以上75℃以下、55℃以上70℃以下、55℃以上65℃以下等であってよい。
本処理工程において、上記水の温度の範囲内で、上記魚類を処理する時間を任意の組み合わせとして適用してよい。 The temperature of the water used in this treatment step is not particularly limited as long as it is 40°C or higher, but may be, for example, 45°C or higher, 50°C or higher, 55°C or higher, 60°C or higher, etc., 90°C or lower, 85°C or higher, etc. It may be below 80°C, below 75°C, below 70°C, below 65°C, etc. For example, 40°C to 90°C, 40°C to 80°C, 40°C to 75°C, 40°C to 70°C, 50°C to 90°C, 50°C to 80°C, 50°C to 75°C , 50°C or higher and 70°C or lower. The temperature of the water may be 55°C or more and 90°C or less, 55°C or more and 80°C or less, 55°C or more and 75°C or less, 55°C or more and 70°C or less, 55°C or more and 65°C or less, and the like.
In this treatment step, any combination of times for treating the fish may be applied within the temperature range of the water.
本処理工程において、上記水の温度の範囲内で、上記魚類を処理する時間を任意の組み合わせとして適用してよい。 The temperature of the water used in this treatment step is not particularly limited as long as it is 40°C or higher, but may be, for example, 45°C or higher, 50°C or higher, 55°C or higher, 60°C or higher, etc., 90°C or lower, 85°C or higher, etc. It may be below 80°C, below 75°C, below 70°C, below 65°C, etc. For example, 40°C to 90°C, 40°C to 80°C, 40°C to 75°C, 40°C to 70°C, 50°C to 90°C, 50°C to 80°C, 50°C to 75°C , 50°C or higher and 70°C or lower. The temperature of the water may be 55°C or more and 90°C or less, 55°C or more and 80°C or less, 55°C or more and 75°C or less, 55°C or more and 70°C or less, 55°C or more and 65°C or less, and the like.
In this treatment step, any combination of times for treating the fish may be applied within the temperature range of the water.
本処理工程は、静置して行ってもよく、攪拌しながら行ってもよく、加圧しながら行ってもよい。本処理工程は、純度を高める等の観点から、繰り返し行ってもよい。
This treatment step may be performed while standing still, may be performed while stirring, or may be performed while pressurizing. This treatment step may be repeated from the viewpoint of increasing purity.
水で魚類を処理した後に液体部分を回収することにより、エクソソームを含む液体(液状物)を得ることができる。本明細書において、本処理工程において回収される液体部分を「水処理液」というものとする。液体部分の回収は、特に限定されないが、例えば、静置して液体部分を分取すること、固体部分を除去すること、遠心分離処理後に上清を回収すること等により行ってもよい。遠心分離処理の条件は、当業者が適宜設定してよい。
本発明のエクソソームを含む組成物の製造方法においては、固体部分を除去するために(固液分離)、特に限定されないが、例えば、濾過処理を行ってもよい。濾過処理の方法も、当業者が適宜選択してよい。
本処理工程は、40℃以上の水と、魚類とを混合する工程を少なくとも含む。
水と魚類の混合物を所定の水温において処理することで、エクソソームが、魚類から移行する。本処理工程は、一種のエクソソームの抽出工程と理解することもできる。
よって、本処理工程としては、特に限定されないが、例えば、40℃以上の水と、魚類とを混合する工程と、得られた混合物を所定の時間経過させる工程と、を含んでいてもよい。当該混合物を所定の時間処理することで、魚類に含まれるエクソソームが、魚類から抽出される。この場合、抽出されたエクソソームは、液体中に含まれることとなる。すなわち、言い換えれば、本処理工程は、40℃以上の水と、魚類とを混合する工程と、所定の水温で、得られた混合物を所定の時間経過させる工程と、水処理液を得る工程と、を含んでいてもよい。
水処理液を得る工程は、得られた混合物を所定の時間経過させて得られたエクソソームが抽出された混合物から、液体部分を分取する工程と言える。 By treating fish with water and collecting the liquid portion, a liquid (liquid) containing exosomes can be obtained. In this specification, the liquid portion recovered in this treatment step is referred to as "water treatment liquid." Recovery of the liquid portion is not particularly limited, and may be performed, for example, by leaving it still and separating the liquid portion, removing the solid portion, or collecting the supernatant after centrifugation. Conditions for centrifugation treatment may be appropriately set by those skilled in the art.
In the method for producing a composition containing exosomes of the present invention, in order to remove solid portions (solid-liquid separation), for example, filtration treatment may be performed, although not particularly limited. The method of filtration treatment may also be appropriately selected by those skilled in the art.
This treatment step includes at least a step of mixing water at 40° C. or higher and fish.
Exosomes are transferred from fish by treating a mixture of water and fish at a predetermined water temperature. This treatment step can also be understood as a type of exosome extraction step.
Therefore, this treatment step is not particularly limited, but may include, for example, a step of mixing water at 40° C. or higher with fish, and a step of allowing the resulting mixture to elapse for a predetermined period of time. By treating the mixture for a predetermined period of time, exosomes contained in fish are extracted from the fish. In this case, the extracted exosomes will be contained in the liquid. In other words, this treatment step includes a step of mixing water with a temperature of 40° C. or higher and fish, a step of allowing the resulting mixture to elapse at a predetermined water temperature for a predetermined time, and a step of obtaining a water treatment liquid. , may also be included.
The process of obtaining a water treatment liquid can be said to be a process of separating a liquid portion from a mixture from which exosomes are extracted, which is obtained by allowing a predetermined period of time to pass through the resulting mixture.
本発明のエクソソームを含む組成物の製造方法においては、固体部分を除去するために(固液分離)、特に限定されないが、例えば、濾過処理を行ってもよい。濾過処理の方法も、当業者が適宜選択してよい。
本処理工程は、40℃以上の水と、魚類とを混合する工程を少なくとも含む。
水と魚類の混合物を所定の水温において処理することで、エクソソームが、魚類から移行する。本処理工程は、一種のエクソソームの抽出工程と理解することもできる。
よって、本処理工程としては、特に限定されないが、例えば、40℃以上の水と、魚類とを混合する工程と、得られた混合物を所定の時間経過させる工程と、を含んでいてもよい。当該混合物を所定の時間処理することで、魚類に含まれるエクソソームが、魚類から抽出される。この場合、抽出されたエクソソームは、液体中に含まれることとなる。すなわち、言い換えれば、本処理工程は、40℃以上の水と、魚類とを混合する工程と、所定の水温で、得られた混合物を所定の時間経過させる工程と、水処理液を得る工程と、を含んでいてもよい。
水処理液を得る工程は、得られた混合物を所定の時間経過させて得られたエクソソームが抽出された混合物から、液体部分を分取する工程と言える。 By treating fish with water and collecting the liquid portion, a liquid (liquid) containing exosomes can be obtained. In this specification, the liquid portion recovered in this treatment step is referred to as "water treatment liquid." Recovery of the liquid portion is not particularly limited, and may be performed, for example, by leaving it still and separating the liquid portion, removing the solid portion, or collecting the supernatant after centrifugation. Conditions for centrifugation treatment may be appropriately set by those skilled in the art.
In the method for producing a composition containing exosomes of the present invention, in order to remove solid portions (solid-liquid separation), for example, filtration treatment may be performed, although not particularly limited. The method of filtration treatment may also be appropriately selected by those skilled in the art.
This treatment step includes at least a step of mixing water at 40° C. or higher and fish.
Exosomes are transferred from fish by treating a mixture of water and fish at a predetermined water temperature. This treatment step can also be understood as a type of exosome extraction step.
Therefore, this treatment step is not particularly limited, but may include, for example, a step of mixing water at 40° C. or higher with fish, and a step of allowing the resulting mixture to elapse for a predetermined period of time. By treating the mixture for a predetermined period of time, exosomes contained in fish are extracted from the fish. In this case, the extracted exosomes will be contained in the liquid. In other words, this treatment step includes a step of mixing water with a temperature of 40° C. or higher and fish, a step of allowing the resulting mixture to elapse at a predetermined water temperature for a predetermined time, and a step of obtaining a water treatment liquid. , may also be included.
The process of obtaining a water treatment liquid can be said to be a process of separating a liquid portion from a mixture from which exosomes are extracted, which is obtained by allowing a predetermined period of time to pass through the resulting mixture.
本発明のエクソソームを含む組成物の製造方法は、水処理液を濃縮する工程をさらに含んでもよい。水処理液を濃縮する工程は、特に限定されないが、例えば、減圧蒸留法等を行うことにより濃縮してもよい。
また、本発明のエクソソームを含む組成物の製造方法は、水処理液を精製する工程をさらに含んでもよい。 The method for producing a composition containing exosomes of the present invention may further include a step of concentrating the water treatment liquid. The step of concentrating the water treatment liquid is not particularly limited, but it may be concentrated by, for example, vacuum distillation.
Furthermore, the method for producing a composition containing exosomes of the present invention may further include a step of purifying a water treatment liquid.
また、本発明のエクソソームを含む組成物の製造方法は、水処理液を精製する工程をさらに含んでもよい。 The method for producing a composition containing exosomes of the present invention may further include a step of concentrating the water treatment liquid. The step of concentrating the water treatment liquid is not particularly limited, but it may be concentrated by, for example, vacuum distillation.
Furthermore, the method for producing a composition containing exosomes of the present invention may further include a step of purifying a water treatment liquid.
本発明のエクソソームを含む組成物の製造方法は、本処理工程に供する試料を水洗浄する工程や下処理する工程をさらに含んでもよい。試料を水洗浄する工程や下処理する工程は、当業者が適宜行うことができるが、例えば、流水に浸すことにより水洗浄を行ってもよく、鱗、内臓、鰓等を除去することにより下処理を行ってもよい。好ましくは、下処理する工程において、試料を、身、頭、骨及び皮に分離させることができれば特に限定されず、例えば、当業者において一般に用いられる方法によって二枚卸や三枚卸にする方法や、高圧水を吹き付けて分離させる高圧水処理等により行ってもよい。
本発明のエクソソームを含む組成物の製造方法は、
所望により、魚類を洗浄する工程や下処理する工程(あるいは、魚類を洗浄するか、及び/又は魚類を下処理する工程)を含んでいてもよく、
40℃以上の水で魚類を処理する工程を含み、好ましくは、40℃以上の水で魚類を所定の時間(好ましくは上記する時間)処理する工程を含む。
本処理工程は、
40℃以上の水と、魚類とを混合する工程と、
所定の水温で、得られた混合物を所定の時間経過させる工程と、(当該工程では、静置していてもよく、撹拌していてもよく、さらに、加圧していてもよい(加圧して静置、加圧して撹拌が挙げられる)。)
水処理液を得る工程と、を含んでいてもよい。水処理液を得る工程は、所定の時間経過させて得られたエクソソームが抽出された混合物から、液体部分を分取する工程であってもよく、好ましくは固液分離により液体部分を得る工程であってもよい。 The method for producing a composition containing exosomes of the present invention may further include a step of washing the sample to be subjected to this treatment step with water and a step of pre-treating the sample. A person skilled in the art can appropriately perform the step of washing the sample with water or pre-treating it, but for example, washing with water may be carried out by immersing the sample in running water, or the step of pre-treating the sample by removing scales, internal organs, gills, etc. Processing may be performed. Preferably, there is no particular limitation as long as the sample can be separated into meat, head, bones, and skin in the pretreatment step, for example, a method commonly used by those skilled in the art, such as dividing into two pieces or three pieces. Alternatively, high-pressure water treatment in which separation is performed by spraying high-pressure water may be performed.
The method for producing a composition containing exosomes of the present invention includes:
If desired, it may include a step of washing the fish or a step of pre-treating the fish (or a step of washing the fish and/or pre-treating the fish),
The method includes a step of treating fish with water at 40° C. or higher, and preferably includes a step of treating fish with water at 40° C. or higher for a predetermined time (preferably the above-mentioned time).
This processing step is
A step of mixing water with a temperature of 40°C or higher and fish;
A step of allowing the obtained mixture to elapse for a predetermined time at a predetermined water temperature; (Standing, pressurizing, and stirring)
The method may include a step of obtaining a water treatment liquid. The step of obtaining a water treatment liquid may be a step of separating a liquid portion from a mixture from which exosomes are extracted after a predetermined period of time, and preferably a step of obtaining a liquid portion by solid-liquid separation. There may be.
本発明のエクソソームを含む組成物の製造方法は、
所望により、魚類を洗浄する工程や下処理する工程(あるいは、魚類を洗浄するか、及び/又は魚類を下処理する工程)を含んでいてもよく、
40℃以上の水で魚類を処理する工程を含み、好ましくは、40℃以上の水で魚類を所定の時間(好ましくは上記する時間)処理する工程を含む。
本処理工程は、
40℃以上の水と、魚類とを混合する工程と、
所定の水温で、得られた混合物を所定の時間経過させる工程と、(当該工程では、静置していてもよく、撹拌していてもよく、さらに、加圧していてもよい(加圧して静置、加圧して撹拌が挙げられる)。)
水処理液を得る工程と、を含んでいてもよい。水処理液を得る工程は、所定の時間経過させて得られたエクソソームが抽出された混合物から、液体部分を分取する工程であってもよく、好ましくは固液分離により液体部分を得る工程であってもよい。 The method for producing a composition containing exosomes of the present invention may further include a step of washing the sample to be subjected to this treatment step with water and a step of pre-treating the sample. A person skilled in the art can appropriately perform the step of washing the sample with water or pre-treating it, but for example, washing with water may be carried out by immersing the sample in running water, or the step of pre-treating the sample by removing scales, internal organs, gills, etc. Processing may be performed. Preferably, there is no particular limitation as long as the sample can be separated into meat, head, bones, and skin in the pretreatment step, for example, a method commonly used by those skilled in the art, such as dividing into two pieces or three pieces. Alternatively, high-pressure water treatment in which separation is performed by spraying high-pressure water may be performed.
The method for producing a composition containing exosomes of the present invention includes:
If desired, it may include a step of washing the fish or a step of pre-treating the fish (or a step of washing the fish and/or pre-treating the fish),
The method includes a step of treating fish with water at 40° C. or higher, and preferably includes a step of treating fish with water at 40° C. or higher for a predetermined time (preferably the above-mentioned time).
This processing step is
A step of mixing water with a temperature of 40°C or higher and fish;
A step of allowing the obtained mixture to elapse for a predetermined time at a predetermined water temperature; (Standing, pressurizing, and stirring)
The method may include a step of obtaining a water treatment liquid. The step of obtaining a water treatment liquid may be a step of separating a liquid portion from a mixture from which exosomes are extracted after a predetermined period of time, and preferably a step of obtaining a liquid portion by solid-liquid separation. There may be.
本発明のエクソソームを含む組成物の製造方法において、本処理工程に供する試料としては、魚類が用いられる。
In the method for producing a composition containing exosomes of the present invention, fish are used as the sample to be subjected to this treatment step.
魚類としては、硬骨魚綱、軟骨魚綱等が挙げられるが、好ましくは、硬骨魚綱である。本明細書において、「魚類」という場合、魚体全体のほか、その組織や臓器等、魚体の一部であってもよい。魚類は、天然魚であってもよく、養殖魚であってもよい。
Examples of fish include teleost fishes, cartilaginous fishes, etc., but preferably teleost fishes. In this specification, the term "fish" refers to not only the entire fish body, but also parts of the fish body, such as its tissues and organs. The fish may be natural fish or farmed fish.
硬骨魚類としては、サケ目、ニシン目、シャチブリ目、キンメダイ目、ギンメダイ目、サケスズキ目、タラ目、ボラ目、スズキ目、フグ目、ウナギ目等が挙げられるが、好ましくは、サケ目である。サケ目としては、サケ科が知られている。
Examples of the teleost fishes include Salmonidae, Herringidae, Orientalidae, Acanthidae, Amaranthidae, Salmonidae, Salmonidae, Codidae, Mulletae, Perciformes, Pufferidae, Eelidae, etc., but Salmonidae is preferable. . Among the salmonids, the family Salmonidae is known.
本明細書において、「サケ科の魚類」とは、サケ目サケ科に属する魚類を意味する。サ科としては、サケ亜科、シロマス亜科、カワヒメマス亜科等が知られている。
As used herein, "fish of the family Salmonidae" means fish belonging to the order Salmonidae. Known members of the family Salmonidae include the subfamily Salmonidae, the subfamily Salmonidae, and the subfamily Salmonidae.
サケ亜科としては、サケ属(タイヘイヨウサケ属、オンコリンクス属ともいう)、タイセイヨウサケ属、イワナ属、イトウ属、コクチマス属等が挙げられる。
サケ属としては、マスノスケ(キングサーモン)、シロザケ、ギンザケ、ベニザケ、ニジマス、サクラマス、ビワマス、クニマス、カラフトマス等が挙げられる。タイセイヨウサケ属としては、タイセイヨウサケ、ブラウントラウト等が挙げられる。イワナ属としては、アメマス、オショロコマ、ミヤベイワナ、ブルックトラウト、イワナ等が挙げられる。イトウ属としては、イトウ等が挙げられる。コクチマス属としては、コクチマス、ガイママス、アムールマス等が挙げられる。 Examples of the subfamily Salmonidae include the genus Salmon (also referred to as the genus Atlantic Salmon and the genus Oncorhynchus), the genus Atlantic Salmon, the genus Char, the genus Itu, and the genus Smallmouth.
Examples of the salmon genus include Masunosuke (king salmon), chum salmon, coho salmon, sockeye salmon, rainbow trout, cherry salmon, loquat trout, kunimasu, pink salmon, and the like. Examples of the Atlantic salmon genus include Atlantic salmon, brown trout, and the like. Examples of the genus Char include Amemasu trout, Oshorokoma, Miyabeiwana, Brook trout, Char, and the like. Examples of the genus Ito include Ito. Examples of the genus Smallmouth include Smallmouth trout, Gaimamus, Amur trout, and the like.
サケ属としては、マスノスケ(キングサーモン)、シロザケ、ギンザケ、ベニザケ、ニジマス、サクラマス、ビワマス、クニマス、カラフトマス等が挙げられる。タイセイヨウサケ属としては、タイセイヨウサケ、ブラウントラウト等が挙げられる。イワナ属としては、アメマス、オショロコマ、ミヤベイワナ、ブルックトラウト、イワナ等が挙げられる。イトウ属としては、イトウ等が挙げられる。コクチマス属としては、コクチマス、ガイママス、アムールマス等が挙げられる。 Examples of the subfamily Salmonidae include the genus Salmon (also referred to as the genus Atlantic Salmon and the genus Oncorhynchus), the genus Atlantic Salmon, the genus Char, the genus Itu, and the genus Smallmouth.
Examples of the salmon genus include Masunosuke (king salmon), chum salmon, coho salmon, sockeye salmon, rainbow trout, cherry salmon, loquat trout, kunimasu, pink salmon, and the like. Examples of the Atlantic salmon genus include Atlantic salmon, brown trout, and the like. Examples of the genus Char include Amemasu trout, Oshorokoma, Miyabeiwana, Brook trout, Char, and the like. Examples of the genus Ito include Ito. Examples of the genus Smallmouth include Smallmouth trout, Gaimamus, Amur trout, and the like.
シロマス亜科としては、シロマス属等が知られる。シロマス属としては、ホワイトフィッシュ、シナノユキマス、オームリ等が挙げられる。
The genus Shiromasu is known as the subfamily Shiromasu. Examples of the genus Whitefish include whitefish, whitefish, and whitefish.
カワヒメマス亜科としては、カワヒメマス属等が知られる。カワヒメマス属としては、キタカワヒメマス、ホンカワヒメマス等が挙げられる。
The genus Kawahimemasu is known as the subfamily Kawahimemasu. Examples of the genus Kawahimemasu include Kitakawahimemasu, Honkawahimemasu, and the like.
サケ科魚類の代表的な魚種として、例えば、マスノスケ(キングサーモン)、シロザケ、ベニザケ(ヒメマス)、ギンザケ、ニジマス、カラフトマス、サクラマス(ヤマメ)、アトランティックサーモン、ブラウントラウト、イトウ、アムールイトウ、イワナ、オショロコマ、ホッキョクイワナ、オームリ、シナノユキマス等が挙げられる。中でも、マスノスケ(キングサーモン)、シロザケ、ギンザケ、ベニザケ、ニジマス、サクラマス、ビワマス、クニマス、カラフトマス、イワナ、ヤマメが好ましく、マスノスケ、ニジマスがより好ましい。
Typical species of salmonids include, for example, king salmon, chum salmon, sockeye salmon, coho salmon, rainbow trout, pink trout, cherry salmon, Atlantic salmon, brown trout, itou, Amur itou, char, Examples include Oshorokoma, Arctic char, Omuri, and Shinano snow trout. Among these, preference is given to salmon salmon (king salmon), chum salmon, coho salmon, sockeye salmon, rainbow trout, cherry salmon, loquat trout, kunimasu, pink trout, char, and yamame, and more preferable are salmon salmon and rainbow trout.
本発明において、魚類は、交配種を用いてもよい。交配種としては、同種間交配種であってもよく、異種間交配種であってもよい。交配種は、好ましくは、異種間交配種である。交配種は、好ましくは、サケ科魚類の異種間交配種であり、より好ましくは、マスノスケ及びニジマスの交配種である。魚類の交配は、当業者が適宜公知の手法により行うことができる。市販されている交配種である魚類を用いてもよい。
In the present invention, a hybrid species of fish may be used. The hybrid species may be a hybrid between the same species or a hybrid between different species. The hybrid is preferably an interspecific hybrid. The hybrid species is preferably an interspecies hybrid of salmonid fish, more preferably a hybrid of Japanese trout and rainbow trout. Crossbreeding of fish can be carried out appropriately by those skilled in the art using known techniques. Commercially available hybrid fish may also be used.
魚類の交配種としては、富士の介(登録商標、以下同様)が好ましい。富士の介は、山梨県水産技術センターによって開発されたマスノスケ(キングサーモン)及びニジマスの交配種である。
富士の介の種苗生産や養殖方法については、2016年に水産庁による「三倍体魚等の水産生物の利用要領」に基づく確認が完了され、2017年から養殖が開始されている。
山梨県水産技術センターでは、富士の介の生産、調製餌による飼育、出荷時の肉色や鮮度保持のための方法等に基準を設けて、管理及び飼育を行っている。富士の介は、キングサーモンの美味しさと、ニジマスの飼育しやすさを兼ね備えたサケ科魚類の異種間交配種である。 As a hybrid fish species, Fuji no Kai (registered trademark, hereinafter the same) is preferred. Fujinosuke is a hybrid of Masunosuke (king salmon) and rainbow trout developed by the Yamanashi Prefectural Fisheries Technology Center.
Concerning the seed production and aquaculture methods of Fujinosuke, the Fisheries Agency completed confirmation in 2016 based on the ``Guidelines for the Use of Aquatic Products such as Triploid Fish,'' and aquaculture began in 2017.
At the Yamanashi Prefectural Fisheries Technology Center, we manage and raise Fujinosuke by setting standards for production, rearing with prepared feed, and methods for preserving meat color and freshness at the time of shipment. Fujinosuke is a cross-species salmonid species that combines the deliciousness of king salmon with the ease of raising rainbow trout.
富士の介の種苗生産や養殖方法については、2016年に水産庁による「三倍体魚等の水産生物の利用要領」に基づく確認が完了され、2017年から養殖が開始されている。
山梨県水産技術センターでは、富士の介の生産、調製餌による飼育、出荷時の肉色や鮮度保持のための方法等に基準を設けて、管理及び飼育を行っている。富士の介は、キングサーモンの美味しさと、ニジマスの飼育しやすさを兼ね備えたサケ科魚類の異種間交配種である。 As a hybrid fish species, Fuji no Kai (registered trademark, hereinafter the same) is preferred. Fujinosuke is a hybrid of Masunosuke (king salmon) and rainbow trout developed by the Yamanashi Prefectural Fisheries Technology Center.
Concerning the seed production and aquaculture methods of Fujinosuke, the Fisheries Agency completed confirmation in 2016 based on the ``Guidelines for the Use of Aquatic Products such as Triploid Fish,'' and aquaculture began in 2017.
At the Yamanashi Prefectural Fisheries Technology Center, we manage and raise Fujinosuke by setting standards for production, rearing with prepared feed, and methods for preserving meat color and freshness at the time of shipment. Fujinosuke is a cross-species salmonid species that combines the deliciousness of king salmon with the ease of raising rainbow trout.
本明細書において、当業者において一般に用いられる方法によって三枚卸に処理した場合に、魚類の頭部は、魚体から切り離される口の先から鰓を覆う骨(鰓蓋骨)の後端までをいうものであり、魚類の骨部は、魚体から切り離される中骨、腹骨、血合い骨、小骨等をいうものであり、魚類の皮部は、魚体から切り離される又は剥ぎ取られる表皮や真皮をいうものであり、鱗を含んでもよい。
本明細書において、魚類の身部は、魚体から頭、骨及び皮を切り離して残される魚肉をいうものである。
魚類の頭部、骨部、皮部には、身部が付着していてもよく、魚類の身部には、頭部、骨部、皮部が付着していてもよい。 In this specification, when a fish head is processed in triplicate by a method commonly used by those skilled in the art, the head of a fish is defined as the length from the tip of the mouth separated from the fish body to the rear end of the bone covering the gills (opercular bone). The bones of fish refer to the middle bones, abdominal bones, blood bones, small bones, etc. that are separated from the fish body, and the skin parts of fish refer to the epidermis and dermis that are separated or stripped from the fish body. It may also include scales.
In this specification, the fish body refers to the fish meat that is left after separating the head, bones, and skin from the fish body.
The body may be attached to the head, bones, and skin of the fish, and the head, bones, and skin may be attached to the body of the fish.
本明細書において、魚類の身部は、魚体から頭、骨及び皮を切り離して残される魚肉をいうものである。
魚類の頭部、骨部、皮部には、身部が付着していてもよく、魚類の身部には、頭部、骨部、皮部が付着していてもよい。 In this specification, when a fish head is processed in triplicate by a method commonly used by those skilled in the art, the head of a fish is defined as the length from the tip of the mouth separated from the fish body to the rear end of the bone covering the gills (opercular bone). The bones of fish refer to the middle bones, abdominal bones, blood bones, small bones, etc. that are separated from the fish body, and the skin parts of fish refer to the epidermis and dermis that are separated or stripped from the fish body. It may also include scales.
In this specification, the fish body refers to the fish meat that is left after separating the head, bones, and skin from the fish body.
The body may be attached to the head, bones, and skin of the fish, and the head, bones, and skin may be attached to the body of the fish.
本発明は、本発明のエクソソームを含む組成物の製造方法によって製造される、エクソソームを含む組成物にも関する。
The present invention also relates to a composition containing exosomes produced by the method for producing a composition containing exosomes of the present invention.
本発明の製造方法によって製造されるエクソソームを含む組成物は、エクソソームを含む。
エクソソームを含むことの確認は、特に限定されないが、例えば、ナノ粒子解析システム(ナノサイトLM10、日本カンタム・デザイン株式会社)等を用いて行うことができる。 A composition containing exosomes produced by the production method of the present invention contains exosomes.
Confirmation that exosomes are included can be performed using, for example, a nanoparticle analysis system (Nanosite LM10, Nippon Quantum Design Co., Ltd.), although there are no particular limitations.
エクソソームを含むことの確認は、特に限定されないが、例えば、ナノ粒子解析システム(ナノサイトLM10、日本カンタム・デザイン株式会社)等を用いて行うことができる。 A composition containing exosomes produced by the production method of the present invention contains exosomes.
Confirmation that exosomes are included can be performed using, for example, a nanoparticle analysis system (Nanosite LM10, Nippon Quantum Design Co., Ltd.), although there are no particular limitations.
本発明の製造方法によって製造されるエクソソームを含む組成物に含まれるエクソソームの量は、特に限定されないが、例えば、粒子数として、2.0×109個/mL以上、5.0×109個/mL以上、1.0×1010個/mL以上、4.0×1010個/mL以上、5.0×1010個/mL以上、6.0×1010個/mL以上、7.0×1010個/mL以上、8.0×1010個/mL以上等であってもよい。
本発明の製造方法によって製造されるエクソソームを含む組成物に含まれるエクソソームの量は、特に限定されないが、魚類の重量あたりの粒子数として、8.0×109個/g以上、9.0×109個/g以上、1.0×1010個/g以上、1.1×1010個/g以上、1.2×1010個/g以上等であってもよい。
本発明の製造方法によって製造されるエクソソームを含む組成物に含まれるエクソソームの粒子径は、特に限定されないが、例えば、平均径として、20nm以上、50nm以上、100nm以上、120nm以上、150nm以上、160nm以上等であってよい。また、平均径は、300nm以下、200nm以下であってよい。
エクソソームの平均径は、20nm以上300nm以下であってよく、当該範囲内で、適宜上記上限値あるいは下限値とした平均径であり得る。例えば、エクソソームの平均径は、100nm以上200nm以下であってよい。
エクソソームの量としての粒子数やエクソソームの平均径は、実施例に記載するように、ナノ粒子解析システムを用いた解析結果として測定可能である。 The amount of exosomes contained in the exosome-containing composition produced by the production method of the present invention is not particularly limited, but for example, the number of particles is 2.0 × 10 9 /mL or more, 5.0 × 10 9 1.0 x 10 10 pieces/mL or more, 4.0 x 10 10 pieces/mL or more, 5.0 x 10 10 pieces/mL or more, 6.0 x 10 10 pieces/mL or more, 7 It may be .0×10 10 pieces/mL or more, 8.0×10 10 pieces/mL or more, etc.
The amount of exosomes contained in the exosome-containing composition produced by the production method of the present invention is not particularly limited, but the number of particles per weight of fish is 8.0 × 10 9 particles / g or more, 9.0 The number may be at least ×10 9 pieces/g, 1.0×10 10 pieces/g or more, 1.1×10 10 pieces/g or more, 1.2×10 10 pieces/g or more, etc.
The particle size of the exosomes contained in the exosome-containing composition produced by the production method of the present invention is not particularly limited, but for example, the average diameter is 20 nm or more, 50 nm or more, 100 nm or more, 120 nm or more, 150 nm or more, 160 nm. The above may be the case. Moreover, the average diameter may be 300 nm or less and 200 nm or less.
The average diameter of exosomes may be 20 nm or more and 300 nm or less, and within this range, the average diameter may be set to the above upper limit or lower limit as appropriate. For example, the average diameter of exosomes may be 100 nm or more and 200 nm or less.
The number of particles as the amount of exosomes and the average diameter of exosomes can be measured as analysis results using a nanoparticle analysis system, as described in Examples.
本発明の製造方法によって製造されるエクソソームを含む組成物に含まれるエクソソームの量は、特に限定されないが、魚類の重量あたりの粒子数として、8.0×109個/g以上、9.0×109個/g以上、1.0×1010個/g以上、1.1×1010個/g以上、1.2×1010個/g以上等であってもよい。
本発明の製造方法によって製造されるエクソソームを含む組成物に含まれるエクソソームの粒子径は、特に限定されないが、例えば、平均径として、20nm以上、50nm以上、100nm以上、120nm以上、150nm以上、160nm以上等であってよい。また、平均径は、300nm以下、200nm以下であってよい。
エクソソームの平均径は、20nm以上300nm以下であってよく、当該範囲内で、適宜上記上限値あるいは下限値とした平均径であり得る。例えば、エクソソームの平均径は、100nm以上200nm以下であってよい。
エクソソームの量としての粒子数やエクソソームの平均径は、実施例に記載するように、ナノ粒子解析システムを用いた解析結果として測定可能である。 The amount of exosomes contained in the exosome-containing composition produced by the production method of the present invention is not particularly limited, but for example, the number of particles is 2.0 × 10 9 /mL or more, 5.0 × 10 9 1.0 x 10 10 pieces/mL or more, 4.0 x 10 10 pieces/mL or more, 5.0 x 10 10 pieces/mL or more, 6.0 x 10 10 pieces/mL or more, 7 It may be .0×10 10 pieces/mL or more, 8.0×10 10 pieces/mL or more, etc.
The amount of exosomes contained in the exosome-containing composition produced by the production method of the present invention is not particularly limited, but the number of particles per weight of fish is 8.0 × 10 9 particles / g or more, 9.0 The number may be at least ×10 9 pieces/g, 1.0×10 10 pieces/g or more, 1.1×10 10 pieces/g or more, 1.2×10 10 pieces/g or more, etc.
The particle size of the exosomes contained in the exosome-containing composition produced by the production method of the present invention is not particularly limited, but for example, the average diameter is 20 nm or more, 50 nm or more, 100 nm or more, 120 nm or more, 150 nm or more, 160 nm. The above may be the case. Moreover, the average diameter may be 300 nm or less and 200 nm or less.
The average diameter of exosomes may be 20 nm or more and 300 nm or less, and within this range, the average diameter may be set to the above upper limit or lower limit as appropriate. For example, the average diameter of exosomes may be 100 nm or more and 200 nm or less.
The number of particles as the amount of exosomes and the average diameter of exosomes can be measured as analysis results using a nanoparticle analysis system, as described in Examples.
本発明の製造方法によって製造されるエクソソームを含む組成物は、水で魚類を処理する工程により溶出される他の水溶性成分を含んでもよい。そのような他の水溶性成分としては、特に限定されないが、例えば、コラーゲン、ゼラチン、ビタミン、脂肪酸、アミノ酸、多糖類、ペプチド等が挙げられる。これら水溶性成分は、魚類に由来する成分であってよい。
The composition containing exosomes produced by the production method of the present invention may also contain other water-soluble components eluted by the process of treating fish with water. Such other water-soluble components include, but are not particularly limited to, collagen, gelatin, vitamins, fatty acids, amino acids, polysaccharides, peptides, and the like. These water-soluble components may be derived from fish.
本発明は、魚類由来のジアシルグリセロール含有エクソソームを含む、組成物にも関する。
当該組成物は、魚類に由来するジアシルグリセロール含有エクソソームを含み、ジアシルグリセロール含有エクソソームにおいては、エクソソームが、ジアシルグリセロールを含んでいることを意味し、エクソソームとジアシルグリセロールが、例えば、別々に一の液中で存在していることを意味するものではない。なお、エクソソームがジアシルグリセロールを含む限りにおいて、ジアシルグリセロール含有エクソソームと、ジアシルグリセロールが別々に一の液中に存在していてもよい。
魚類に由来するジアシルグリセロール含有エクソソームにおいては、エクソソームの膜構成成分として、ジアシルグリセロールを含んでいてもよく、エクソソームの小胞内にジアシルグリセロールを含んでいてもよい。
ジアシルグリセロール(DAG:diacylglycerol)は、グリセリンに2つの脂肪酸がエステル結合を介して結合した分子であり、多彩な生理作用が注目されている。
したがって、本発明における魚類由来のジアシルグリセロール含有エクソソームを含む、組成物は、エクソソームによる生理作用だけではなく、ジアシルグリセロールによる生理作用も期待できる組成物である。 The present invention also relates to compositions comprising diacylglycerol-containing exosomes derived from fish.
The composition contains diacylglycerol-containing exosomes derived from fish, and in diacylglycerol-containing exosomes, the exosomes contain diacylglycerol, and the exosomes and diacylglycerol are, for example, separated into one liquid. It does not mean that it exists inside. Note that as long as the exosome contains diacylglycerol, the diacylglycerol-containing exosome and diacylglycerol may be present separately in one liquid.
Diacylglycerol-containing exosomes derived from fish may contain diacylglycerol as a membrane component of the exosome, or may contain diacylglycerol within the vesicles of the exosome.
BACKGROUND ART Diacylglycerol (DAG) is a molecule in which two fatty acids are bonded to glycerin via an ester bond, and has attracted attention for its various physiological effects.
Therefore, the composition of the present invention containing fish-derived diacylglycerol-containing exosomes is a composition that can be expected to have not only physiological effects due to exosomes but also physiological effects due to diacylglycerol.
当該組成物は、魚類に由来するジアシルグリセロール含有エクソソームを含み、ジアシルグリセロール含有エクソソームにおいては、エクソソームが、ジアシルグリセロールを含んでいることを意味し、エクソソームとジアシルグリセロールが、例えば、別々に一の液中で存在していることを意味するものではない。なお、エクソソームがジアシルグリセロールを含む限りにおいて、ジアシルグリセロール含有エクソソームと、ジアシルグリセロールが別々に一の液中に存在していてもよい。
魚類に由来するジアシルグリセロール含有エクソソームにおいては、エクソソームの膜構成成分として、ジアシルグリセロールを含んでいてもよく、エクソソームの小胞内にジアシルグリセロールを含んでいてもよい。
ジアシルグリセロール(DAG:diacylglycerol)は、グリセリンに2つの脂肪酸がエステル結合を介して結合した分子であり、多彩な生理作用が注目されている。
したがって、本発明における魚類由来のジアシルグリセロール含有エクソソームを含む、組成物は、エクソソームによる生理作用だけではなく、ジアシルグリセロールによる生理作用も期待できる組成物である。 The present invention also relates to compositions comprising diacylglycerol-containing exosomes derived from fish.
The composition contains diacylglycerol-containing exosomes derived from fish, and in diacylglycerol-containing exosomes, the exosomes contain diacylglycerol, and the exosomes and diacylglycerol are, for example, separated into one liquid. It does not mean that it exists inside. Note that as long as the exosome contains diacylglycerol, the diacylglycerol-containing exosome and diacylglycerol may be present separately in one liquid.
Diacylglycerol-containing exosomes derived from fish may contain diacylglycerol as a membrane component of the exosome, or may contain diacylglycerol within the vesicles of the exosome.
BACKGROUND ART Diacylglycerol (DAG) is a molecule in which two fatty acids are bonded to glycerin via an ester bond, and has attracted attention for its various physiological effects.
Therefore, the composition of the present invention containing fish-derived diacylglycerol-containing exosomes is a composition that can be expected to have not only physiological effects due to exosomes but also physiological effects due to diacylglycerol.
エクソソーム中のジアシルグリセロールの含有量は、3pmol/1010粒子以上であってもよく、4pmol/1010粒子以上であってもよく、4.5pmol/1010粒子以上であってもよく、5pmol/1010粒子以上であってもよく、5.5pmol/1010粒子以上であってもよく、6pmol/1010粒子以上であってもよく、6.5pmol/1010粒子以上であってもよい。
また、エクソソーム中のジアシルグリセロールの含有量は、9pmol/1010粒子以下であってもよく、8pmol/1010粒子以下であってもよく、7.5pmol/1010粒子以下であってもよく、7pmol/1010粒子以下であってもよい。
エクソソーム中のジアシルグリセロールの含有量は、上記いずれかの範囲内で、例えば、4pmol/1010粒子以上8pmol/1010粒子以下、4.5pmol/1010粒子以上8pmol/1010粒子以下、5.5pmol/1010粒子以上7pmol/1010粒子以下等であってもよい。
エクソソーム中のジアシルグリセロールの含有量は、実施例に記載するように、DAG(ジアシルグリセロール)アッセイキットを用いた解析結果として測定可能である。エクソソーム中のジアシルグリセロールの含有量は、エクソソームを含む組成物をPBS等の溶液あるいは溶媒(本処理工程において用いられる水であってもよい)で希釈して得られたエクソソーム溶液を用いた解析結果として測定される値であってよい。 The content of diacylglycerol in exosomes may be 3 pmol / 10 particles or more, 4 pmol/10 particles or more, 4.5 pmol/ 10 particles or more, or 5 pmol/10 particles or more. The amount may be 10 10 particles or more, 5.5 pmol/10 10 particles or more, 6 pmol/10 10 particles or more, or 6.5 pmol/10 10 particles or more.
Further, the content of diacylglycerol in the exosomes may be 9 pmol/ 10 particles or less, 8 pmol/ 10 particles or less, 7.5 pmol/ 10 particles or less, The amount may be 7 pmol/10 10 particles or less.
The content of diacylglycerol in exosomes is within any of the above ranges, for example, 4 pmol/10 10 particles or more and 8 pmol/10 10 particles or less, 4.5 pmol/ 10 10 particles or more and 8 pmol/ 10 10 particles or less, 5. The amount may be 5 pmol/ 10 10 particles or more and 7 pmol/ 10 10 particles or less.
The content of diacylglycerol in exosomes can be measured as an analysis result using a DAG (diacylglycerol) assay kit, as described in the Examples. The content of diacylglycerol in exosomes was determined by analysis using an exosome solution obtained by diluting a composition containing exosomes with a solution such as PBS or a solvent (or water used in this treatment step). It may be a value measured as .
また、エクソソーム中のジアシルグリセロールの含有量は、9pmol/1010粒子以下であってもよく、8pmol/1010粒子以下であってもよく、7.5pmol/1010粒子以下であってもよく、7pmol/1010粒子以下であってもよい。
エクソソーム中のジアシルグリセロールの含有量は、上記いずれかの範囲内で、例えば、4pmol/1010粒子以上8pmol/1010粒子以下、4.5pmol/1010粒子以上8pmol/1010粒子以下、5.5pmol/1010粒子以上7pmol/1010粒子以下等であってもよい。
エクソソーム中のジアシルグリセロールの含有量は、実施例に記載するように、DAG(ジアシルグリセロール)アッセイキットを用いた解析結果として測定可能である。エクソソーム中のジアシルグリセロールの含有量は、エクソソームを含む組成物をPBS等の溶液あるいは溶媒(本処理工程において用いられる水であってもよい)で希釈して得られたエクソソーム溶液を用いた解析結果として測定される値であってよい。 The content of diacylglycerol in exosomes may be 3 pmol / 10 particles or more, 4 pmol/10 particles or more, 4.5 pmol/ 10 particles or more, or 5 pmol/10 particles or more. The amount may be 10 10 particles or more, 5.5 pmol/10 10 particles or more, 6 pmol/10 10 particles or more, or 6.5 pmol/10 10 particles or more.
Further, the content of diacylglycerol in the exosomes may be 9 pmol/ 10 particles or less, 8 pmol/ 10 particles or less, 7.5 pmol/ 10 particles or less, The amount may be 7 pmol/10 10 particles or less.
The content of diacylglycerol in exosomes is within any of the above ranges, for example, 4 pmol/10 10 particles or more and 8 pmol/10 10 particles or less, 4.5 pmol/ 10 10 particles or more and 8 pmol/ 10 10 particles or less, 5. The amount may be 5 pmol/ 10 10 particles or more and 7 pmol/ 10 10 particles or less.
The content of diacylglycerol in exosomes can be measured as an analysis result using a DAG (diacylglycerol) assay kit, as described in the Examples. The content of diacylglycerol in exosomes was determined by analysis using an exosome solution obtained by diluting a composition containing exosomes with a solution such as PBS or a solvent (or water used in this treatment step). It may be a value measured as .
ジアシルグリセロールは、グリセリンの1位と2位に脂肪酸が結合した1,2体(1,2-DAG)と、グリセリンの1位と3位に脂肪酸が結合した1,3体(1,3-DAG)のいずれの構造であってもよい。
ジアシルグリセロールを構成する脂肪酸としては、飽和脂肪酸であってもよく、不飽和脂肪酸であってもよく、飽和脂肪酸と不飽和脂肪酸の両方であってもよく、いずれかであってもよい。
不飽和脂肪酸は、ω-3(n-3)脂肪酸であってもよく、ω-6(n-6)脂肪酸であってもよく、ω-9(n-9)脂肪酸であってもよく、これらの組み合わせであってもよい。
不飽和脂肪酸の二重結合の数は、1~6程度であり、特に限定されない。
脂肪酸の炭素数は、2以上22以下程度であり、例えば2以上、4以上、16以上、18以上等であってもよく、22以下、20以下、18以下等であってもよい。脂肪酸の炭素数は、上記範囲内で、例えば、18以上22以下、18以上20以下等であってもよい。
ジアシルグリセロールを構成する脂肪酸としては、例えば、酢酸、酪酸、パルミチン酸、ステアリン酸、オレイン酸、リノール酸、α-リノレン酸、γ-リノレン酸、ジホモ-γ-リノレン酸、アラキドン酸、エイコセン酸、エイコサペンタエン酸(EPA)、ドコサペンタエン酸、ドコサヘキサエン酸(DHA)等が挙げられる。
中でも、炭素数が18又は20である脂肪酸であることが好ましく、エクソソーム中のジアシルグリセロールの含有量は、エクソソーム中の炭素数18又は20の脂肪酸が少なくとも1つ結合したジアシルグリセロールの含有量であってもよく、エクソソーム中の炭素数18又は20の脂肪酸が2つ結合したジアシルグリセロールの含有量であってもよい。 Diacylglycerol consists of 1,2-diacyl glycerol (1,2-DAG), in which fatty acids are bound to the 1st and 2nd positions of glycerin, and 1,3-diacylglycerol (1,3-DAG), in which fatty acids are bound to the 1st and 3rd positions of glycerin. DAG) may be any structure.
The fatty acids constituting diacylglycerol may be saturated fatty acids, unsaturated fatty acids, both saturated fatty acids and unsaturated fatty acids, or either one.
The unsaturated fatty acids may be ω-3 (n-3) fatty acids, ω-6 (n-6) fatty acids, ω-9 (n-9) fatty acids, A combination of these may also be used.
The number of double bonds in the unsaturated fatty acid is about 1 to 6 and is not particularly limited.
The number of carbon atoms in the fatty acid is about 2 or more and 22 or less, and may be, for example, 2 or more, 4 or more, 16 or more, 18 or more, or 22 or less, 20 or less, 18 or less. The number of carbon atoms in the fatty acid may be within the above range, for example, 18 or more and 22 or less, 18 or more and 20 or less.
Examples of fatty acids constituting diacylglycerol include acetic acid, butyric acid, palmitic acid, stearic acid, oleic acid, linoleic acid, α-linolenic acid, γ-linolenic acid, dihomo-γ-linolenic acid, arachidonic acid, eicosenoic acid, Examples include eicosapentaenoic acid (EPA), docosapentaenoic acid, docosahexaenoic acid (DHA), and the like.
Among these, fatty acids having 18 or 20 carbon atoms are preferable, and the content of diacylglycerol in exosomes is the content of diacylglycerol to which at least one fatty acid having 18 or 20 carbon atoms is bonded in exosomes. It may be the content of diacylglycerol in which two fatty acids having 18 or 20 carbon atoms are bonded in the exosome.
ジアシルグリセロールを構成する脂肪酸としては、飽和脂肪酸であってもよく、不飽和脂肪酸であってもよく、飽和脂肪酸と不飽和脂肪酸の両方であってもよく、いずれかであってもよい。
不飽和脂肪酸は、ω-3(n-3)脂肪酸であってもよく、ω-6(n-6)脂肪酸であってもよく、ω-9(n-9)脂肪酸であってもよく、これらの組み合わせであってもよい。
不飽和脂肪酸の二重結合の数は、1~6程度であり、特に限定されない。
脂肪酸の炭素数は、2以上22以下程度であり、例えば2以上、4以上、16以上、18以上等であってもよく、22以下、20以下、18以下等であってもよい。脂肪酸の炭素数は、上記範囲内で、例えば、18以上22以下、18以上20以下等であってもよい。
ジアシルグリセロールを構成する脂肪酸としては、例えば、酢酸、酪酸、パルミチン酸、ステアリン酸、オレイン酸、リノール酸、α-リノレン酸、γ-リノレン酸、ジホモ-γ-リノレン酸、アラキドン酸、エイコセン酸、エイコサペンタエン酸(EPA)、ドコサペンタエン酸、ドコサヘキサエン酸(DHA)等が挙げられる。
中でも、炭素数が18又は20である脂肪酸であることが好ましく、エクソソーム中のジアシルグリセロールの含有量は、エクソソーム中の炭素数18又は20の脂肪酸が少なくとも1つ結合したジアシルグリセロールの含有量であってもよく、エクソソーム中の炭素数18又は20の脂肪酸が2つ結合したジアシルグリセロールの含有量であってもよい。 Diacylglycerol consists of 1,2-diacyl glycerol (1,2-DAG), in which fatty acids are bound to the 1st and 2nd positions of glycerin, and 1,3-diacylglycerol (1,3-DAG), in which fatty acids are bound to the 1st and 3rd positions of glycerin. DAG) may be any structure.
The fatty acids constituting diacylglycerol may be saturated fatty acids, unsaturated fatty acids, both saturated fatty acids and unsaturated fatty acids, or either one.
The unsaturated fatty acids may be ω-3 (n-3) fatty acids, ω-6 (n-6) fatty acids, ω-9 (n-9) fatty acids, A combination of these may also be used.
The number of double bonds in the unsaturated fatty acid is about 1 to 6 and is not particularly limited.
The number of carbon atoms in the fatty acid is about 2 or more and 22 or less, and may be, for example, 2 or more, 4 or more, 16 or more, 18 or more, or 22 or less, 20 or less, 18 or less. The number of carbon atoms in the fatty acid may be within the above range, for example, 18 or more and 22 or less, 18 or more and 20 or less.
Examples of fatty acids constituting diacylglycerol include acetic acid, butyric acid, palmitic acid, stearic acid, oleic acid, linoleic acid, α-linolenic acid, γ-linolenic acid, dihomo-γ-linolenic acid, arachidonic acid, eicosenoic acid, Examples include eicosapentaenoic acid (EPA), docosapentaenoic acid, docosahexaenoic acid (DHA), and the like.
Among these, fatty acids having 18 or 20 carbon atoms are preferable, and the content of diacylglycerol in exosomes is the content of diacylglycerol to which at least one fatty acid having 18 or 20 carbon atoms is bonded in exosomes. It may be the content of diacylglycerol in which two fatty acids having 18 or 20 carbon atoms are bonded in the exosome.
本発明の魚類由来のジアシルグリセロール含有エクソソームを含む組成物は、エクソソームの単離方法として当業者に周知の方法等を用いて、魚類からエクソソームを単離することによって製造してもよい。
また、魚類由来のジアシルグリセロール含有エクソソームを含む組成物は、本発明の製造方法によって製造されてもよい。すなわち、40℃以上の水で魚類を処理する工程を含む、エクソソームを含む組成物の製造方法によって製造されるエクソソームを含む組成物に含まれるエクソソームは、ジアシルグリセロールを含有してもよい。 The composition containing diacylglycerol-containing exosomes derived from fish of the present invention may be produced by isolating exosomes from fish using methods well known to those skilled in the art as methods for isolating exosomes.
Furthermore, a composition containing fish-derived diacylglycerol-containing exosomes may be produced by the production method of the present invention. That is, exosomes contained in a composition containing exosomes produced by a method for producing a composition containing exosomes, which includes a step of treating fish with water at 40° C. or higher, may contain diacylglycerol.
また、魚類由来のジアシルグリセロール含有エクソソームを含む組成物は、本発明の製造方法によって製造されてもよい。すなわち、40℃以上の水で魚類を処理する工程を含む、エクソソームを含む組成物の製造方法によって製造されるエクソソームを含む組成物に含まれるエクソソームは、ジアシルグリセロールを含有してもよい。 The composition containing diacylglycerol-containing exosomes derived from fish of the present invention may be produced by isolating exosomes from fish using methods well known to those skilled in the art as methods for isolating exosomes.
Furthermore, a composition containing fish-derived diacylglycerol-containing exosomes may be produced by the production method of the present invention. That is, exosomes contained in a composition containing exosomes produced by a method for producing a composition containing exosomes, which includes a step of treating fish with water at 40° C. or higher, may contain diacylglycerol.
本発明のエクソソームを含む組成物は、40℃以上の水で魚類を処理する工程を含む、エクソソームを含む組成物の製造方法によって製造されるエクソソームを含む組成物であってもよく、魚類由来のジアシルグリセロール含有エクソソームを含む、組成物であってもよい。
かかる組成物は、エクソソームに加えて、任意の他の成分を含んでもよい。任意の他の成分としては、組成物の形態や目的に応じて当業者が適宜判断し得るが、例えば、コラーゲン、ゼラチン、ビタミン、脂肪酸、アミノ酸、多糖類、ペプチド等であってよく、これら成分は、水で魚類を処理する工程により溶出され得る成分、すなわち、魚類に由来する成分であってよいし、添加した成分であってもよい。
エクソソームを含む組成物には、その他、以下に記す用途において汎用される添加剤等を含んでいてもよい。また、エクソソームを含む組成物には、エクソソームの細胞内移行や細胞標的作用を促進するための成分、緩衝成分、生理食塩水等を含んでもよいし、以下に記す用途において用いられる他の有効成分を含んでいてもよい。 The composition containing exosomes of the present invention may be a composition containing exosomes produced by a method for producing a composition containing exosomes, which includes a step of treating fish with water at 40°C or higher, and may be a composition containing exosomes produced from a fish-derived composition. The composition may include a diacylglycerol-containing exosome.
Such compositions may include any other components in addition to exosomes. Optional other components can be appropriately determined by those skilled in the art depending on the form and purpose of the composition, and may include, for example, collagen, gelatin, vitamins, fatty acids, amino acids, polysaccharides, peptides, etc. may be a component that can be eluted by the process of treating fish with water, that is, a component derived from fish, or may be an added component.
The composition containing exosomes may also contain additives commonly used in the uses described below. In addition, the composition containing exosomes may contain components for promoting the internalization of exosomes and cell targeting effects, buffer components, physiological saline, etc., and other active ingredients used in the following applications. May contain.
かかる組成物は、エクソソームに加えて、任意の他の成分を含んでもよい。任意の他の成分としては、組成物の形態や目的に応じて当業者が適宜判断し得るが、例えば、コラーゲン、ゼラチン、ビタミン、脂肪酸、アミノ酸、多糖類、ペプチド等であってよく、これら成分は、水で魚類を処理する工程により溶出され得る成分、すなわち、魚類に由来する成分であってよいし、添加した成分であってもよい。
エクソソームを含む組成物には、その他、以下に記す用途において汎用される添加剤等を含んでいてもよい。また、エクソソームを含む組成物には、エクソソームの細胞内移行や細胞標的作用を促進するための成分、緩衝成分、生理食塩水等を含んでもよいし、以下に記す用途において用いられる他の有効成分を含んでいてもよい。 The composition containing exosomes of the present invention may be a composition containing exosomes produced by a method for producing a composition containing exosomes, which includes a step of treating fish with water at 40°C or higher, and may be a composition containing exosomes produced from a fish-derived composition. The composition may include a diacylglycerol-containing exosome.
Such compositions may include any other components in addition to exosomes. Optional other components can be appropriately determined by those skilled in the art depending on the form and purpose of the composition, and may include, for example, collagen, gelatin, vitamins, fatty acids, amino acids, polysaccharides, peptides, etc. may be a component that can be eluted by the process of treating fish with water, that is, a component derived from fish, or may be an added component.
The composition containing exosomes may also contain additives commonly used in the uses described below. In addition, the composition containing exosomes may contain components for promoting the internalization of exosomes and cell targeting effects, buffer components, physiological saline, etc., and other active ingredients used in the following applications. May contain.
本発明のエクソソームを含む組成物は、経口剤や外用剤に利用可能である。
本発明のエクソソームを含む組成物は、そのまま用いてもよいが、エクソソームを濃縮したり、抽出したりしてもよい。
本発明のエクソソームを含む組成物は、サプリメント、総合ビタミン剤、複合ビタミン剤、アミノ酸剤、滋養強壮変質剤、コンドロイチン製剤、食品強化剤、臓器製剤、たんぱくアミノ酸製剤、しわ取りパック用化粧料、コールドクリーム、ハンドクリーム、ひげそり用クリーム、ファウンデーションクリーム、薬用クリーム、頭髪用化粧品、セッティングローション、ヘアークリーム、バスオイル、バスソルト、ベビーオイル、ベビーパウダー等として用いてもよい。
なお、本発明のエクソソームを含む組成物は、食品としてもよく、化粧品としてもよく、医薬品としてもよい。対象としては、ヒトが好ましいが、ペットフード、ペット用補助食品、ペット用サプリメントとして、ペット用としてもよい。
経口剤や外用剤、各種用途における製剤としては、特に限定されず、従来公知の方法に従って、調製可能である。 The composition containing the exosome of the present invention can be used as an oral preparation or an external preparation.
The composition containing exosomes of the present invention may be used as is, or the exosomes may be concentrated or extracted.
The composition containing exosomes of the present invention can be used in supplements, multivitamin preparations, multivitamin preparations, amino acid preparations, nourishing and tonic altering agents, chondroitin preparations, food fortifying agents, organ preparations, protein and amino acid preparations, cosmetics for anti-wrinkle packs, cold It may be used as a cream, hand cream, shaving cream, foundation cream, medicated cream, hair cosmetic, setting lotion, hair cream, bath oil, bath salt, baby oil, baby powder, etc.
In addition, the composition containing the exosome of the present invention may be used as a food, a cosmetic, or a pharmaceutical. The target is preferably humans, but it may also be used for pets as pet food, supplementary food for pets, and supplements for pets.
Oral preparations, external preparations, and preparations for various uses are not particularly limited, and can be prepared according to conventionally known methods.
本発明のエクソソームを含む組成物は、そのまま用いてもよいが、エクソソームを濃縮したり、抽出したりしてもよい。
本発明のエクソソームを含む組成物は、サプリメント、総合ビタミン剤、複合ビタミン剤、アミノ酸剤、滋養強壮変質剤、コンドロイチン製剤、食品強化剤、臓器製剤、たんぱくアミノ酸製剤、しわ取りパック用化粧料、コールドクリーム、ハンドクリーム、ひげそり用クリーム、ファウンデーションクリーム、薬用クリーム、頭髪用化粧品、セッティングローション、ヘアークリーム、バスオイル、バスソルト、ベビーオイル、ベビーパウダー等として用いてもよい。
なお、本発明のエクソソームを含む組成物は、食品としてもよく、化粧品としてもよく、医薬品としてもよい。対象としては、ヒトが好ましいが、ペットフード、ペット用補助食品、ペット用サプリメントとして、ペット用としてもよい。
経口剤や外用剤、各種用途における製剤としては、特に限定されず、従来公知の方法に従って、調製可能である。 The composition containing the exosome of the present invention can be used as an oral preparation or an external preparation.
The composition containing exosomes of the present invention may be used as is, or the exosomes may be concentrated or extracted.
The composition containing exosomes of the present invention can be used in supplements, multivitamin preparations, multivitamin preparations, amino acid preparations, nourishing and tonic altering agents, chondroitin preparations, food fortifying agents, organ preparations, protein and amino acid preparations, cosmetics for anti-wrinkle packs, cold It may be used as a cream, hand cream, shaving cream, foundation cream, medicated cream, hair cosmetic, setting lotion, hair cream, bath oil, bath salt, baby oil, baby powder, etc.
In addition, the composition containing the exosome of the present invention may be used as a food, a cosmetic, or a pharmaceutical. The target is preferably humans, but it may also be used for pets as pet food, supplementary food for pets, and supplements for pets.
Oral preparations, external preparations, and preparations for various uses are not particularly limited, and can be prepared according to conventionally known methods.
本発明の魚類由来のジアシルグリセロール含有エクソソームを含む組成物は、例えば、一般食品の他、ジアシルグリセロールやエクソソームの生理効果を標榜した特定保健用食品、栄養機能食品、機能性表示食品等の保健機能食品や、健康食品(栄養補助食品、健康補助食品、栄養調整食品等といった表示が付された食品を含む)、サプリメント等に用いてもよい。本発明の魚類由来のジアシルグリセロール含有エクソソームを含む組成物の具体的な用途としては、例えば、ジアシルグリセロールやエクソソームの生理効果に由来して、例えば、空腹時の中性脂肪を低下させる、食後の血中中性脂肪の上昇を抑制する、LDLコレステロールを低下させる、ボディマス指数(body mass index:BMI)の低減、肥満者での体脂肪蓄積を抑制する、体脂肪の低減、生活習慣病のリスクを低減する等の健康増進を目的とした用途であってもよい。
本発明の魚類由来のジアシルグリセロール含有エクソソームを含む組成物の有用性は、エクソソームは胃腸で分解されずに、生体に吸収され、肝臓やその他の臓器に運ばれて、内容物であるジアシルグリセロールを放出し、ジアシルグリセロールが肝臓やその他の臓器において作用する点にあるとも考えられる。 The composition containing fish-derived diacylglycerol-containing exosomes of the present invention can be used, for example, in addition to general foods, foods with health functions such as foods for specified health uses, foods with nutritional function claims, and foods with functional claims that claim the physiological effects of diacylglycerol and exosomes. It may be used in foods, health foods (including foods labeled as nutritional supplements, health supplements, nutritional adjustment foods, etc.), supplements, and the like. Specific uses of the composition containing fish-derived diacylglycerol-containing exosomes of the present invention include, for example, reducing fasting neutral fat, postprandial Suppressing the rise in blood triglycerides, lowering LDL cholesterol, reducing body mass index (BMI), suppressing body fat accumulation in obese people, reducing body fat, risk of lifestyle-related diseases It may also be used for the purpose of promoting health, such as reducing.
The usefulness of the composition containing diacylglycerol-containing exosomes derived from fish of the present invention is that the exosomes are absorbed into the body without being degraded in the gastrointestinal tract, are transported to the liver and other organs, and release the diacylglycerol content. It is also believed that diacylglycerol acts in the liver and other organs.
本発明の魚類由来のジアシルグリセロール含有エクソソームを含む組成物の有用性は、エクソソームは胃腸で分解されずに、生体に吸収され、肝臓やその他の臓器に運ばれて、内容物であるジアシルグリセロールを放出し、ジアシルグリセロールが肝臓やその他の臓器において作用する点にあるとも考えられる。 The composition containing fish-derived diacylglycerol-containing exosomes of the present invention can be used, for example, in addition to general foods, foods with health functions such as foods for specified health uses, foods with nutritional function claims, and foods with functional claims that claim the physiological effects of diacylglycerol and exosomes. It may be used in foods, health foods (including foods labeled as nutritional supplements, health supplements, nutritional adjustment foods, etc.), supplements, and the like. Specific uses of the composition containing fish-derived diacylglycerol-containing exosomes of the present invention include, for example, reducing fasting neutral fat, postprandial Suppressing the rise in blood triglycerides, lowering LDL cholesterol, reducing body mass index (BMI), suppressing body fat accumulation in obese people, reducing body fat, risk of lifestyle-related diseases It may also be used for the purpose of promoting health, such as reducing.
The usefulness of the composition containing diacylglycerol-containing exosomes derived from fish of the present invention is that the exosomes are absorbed into the body without being degraded in the gastrointestinal tract, are transported to the liver and other organs, and release the diacylglycerol content. It is also believed that diacylglycerol acts in the liver and other organs.
以下、本実施の形態を実施例及び比較例によってさらに具体的に説明するが、本実施の形態はこれらの実施例のみに限定されるものではない。
Hereinafter, this embodiment will be described in more detail with reference to Examples and Comparative Examples, but this embodiment is not limited to these Examples.
富士の介を3枚卸に処理し、第1部位(頭部、骨部及び皮部)と、第2部位(身部)とに分離した。第2部位200gをブレンダー処理し、水600mL(約3倍量)を添加した。網漉しを行った後、遠心分離した。浮上油をうまく分離できず、エクソソームは得られなかった。
Three Fujinosuke pieces were processed and separated into a first part (head, bone, and skin) and a second part (body). 200 g of the second portion was blended and 600 mL of water (approximately 3 times the amount) was added. After filtering through a sieve, centrifugation was performed. The floating oil could not be successfully separated, and exosomes were not obtained.
富士の介を3枚卸に処理し、第1部位(頭部、骨部及び皮部)と、第2部位(身部)とに分離した。第2部位2.1kgを細断し、水5000mL(約2.5倍量)を添加した。90℃で30分間加熱し、静置後浮上油を得、吸引ろ過を行った後、遠心分離(3500rpm)した。浮上油中で、エクソソームの存在を確認することはできなかったが、浮上油に対して、PBSを加えたところ、エクソソームの存在が確認できた。
Three Fujinosuke pieces were processed and separated into a first part (head, bone, and skin) and a second part (body). 2.1 kg of the second part was cut into pieces, and 5000 mL of water (approximately 2.5 times the amount) was added. The mixture was heated at 90° C. for 30 minutes, left to stand, and a floating oil was obtained. After suction filtration, the mixture was centrifuged (3500 rpm). Although it was not possible to confirm the presence of exosomes in the floating oil, when PBS was added to the floating oil, the presence of exosomes was confirmed.
富士の介を3枚卸に処理し、第1部位(頭部、骨部及び皮部)と、第2部位(身部)とに分離した。第1部位又は第2部位のそれぞれ500gに対して、生理食塩水1000mL(約2倍量)を添加した。60℃で3時間加熱し、ろ紙ろ過を行って固液分離し、エクソソームを含む組成物をそれぞれ得た。
Three Fujinosuke pieces were processed and separated into a first part (head, bone, and skin) and a second part (body). 1000 mL (approximately twice the volume) of physiological saline was added to 500 g of each of the first site and the second site. The mixture was heated at 60° C. for 3 hours and subjected to solid-liquid separation by filter paper filtration to obtain each composition containing exosomes.
得られたエクソソームの解析には、ナノ粒子解析システム(ナノサイトLM10、日本カンタム・デザイン株式会社、以下同様)を用いて行った。結果を表1に示す。なお、解析条件は以下のとおりである。
Details
NTA Version: NTA 3.4 Build 3.4.4
Script Used: SOP Standard Measurements
Capture Settings
Camera Type: sCMOS
Laser Type: Blue405
Camera Level: 13
Slider Shutter: 1232
Slider Gain: 219
DPS: 25.0
Number of Frames: 1300
Temperature: 26~27℃
Viscosity: (Water) 0.9 cP
Dilution factor: Dilution not recorded
Analysis Settings
Detect Threshold: 7
Blur Size: Auto
Max Jump Distance: Auto The obtained exosomes were analyzed using a nanoparticle analysis system (Nanosite LM10, Nippon Quantum Design Co., Ltd., hereinafter the same). The results are shown in Table 1. The analysis conditions are as follows.
Details
NTA Version: NTA 3.4 Build 3.4.4
Script Used: SOP Standard Measurements
Capture Settings
Camera Type: sCMOS
Laser Type: Blue405
Camera level: 13
Slider Shutter: 1232
Slider Gain: 219
DPS: 25.0
Number of frames: 1300
Temperature: 26-27℃
Viscosity: (Water) 0.9 cP
Dilution factor: Dilution not recorded
Analysis Settings
Detect Threshold: 7
Blur Size: Auto
Max Jump Distance: Auto
Details
NTA Version: NTA 3.4 Build 3.4.4
Script Used: SOP Standard Measurements
Capture Settings
Camera Type: sCMOS
Laser Type: Blue405
Camera Level: 13
Slider Shutter: 1232
Slider Gain: 219
DPS: 25.0
Number of Frames: 1300
Temperature: 26~27℃
Viscosity: (Water) 0.9 cP
Dilution factor: Dilution not recorded
Analysis Settings
Detect Threshold: 7
Blur Size: Auto
Max Jump Distance: Auto The obtained exosomes were analyzed using a nanoparticle analysis system (Nanosite LM10, Nippon Quantum Design Co., Ltd., hereinafter the same). The results are shown in Table 1. The analysis conditions are as follows.
Details
NTA Version: NTA 3.4 Build 3.4.4
Script Used: SOP Standard Measurements
Capture Settings
Camera Type: sCMOS
Laser Type: Blue405
Camera level: 13
Slider Shutter: 1232
Slider Gain: 219
DPS: 25.0
Number of frames: 1300
Temperature: 26-27℃
Viscosity: (Water) 0.9 cP
Dilution factor: Dilution not recorded
Analysis Settings
Detect Threshold: 7
Blur Size: Auto
Max Jump Distance: Auto
富士の介を3枚卸に処理し、第1部位(骨部及び皮部)と、第2部位(身部)とに分離した。第1部位又は第2部位のそれぞれ300gに対して、生理食塩水600mL(約2倍量)を添加した。40℃又は60℃で30分間加熱し、ろ紙ろ過を行って固液分離し、エクソソームを含む組成物をそれぞれ得た。
なお、40℃3時間加熱を試みたが、腐敗の可能性があったため、エクソソームを含む組成物の製造を中止した。 Three Fujinosuke pieces were processed and separated into a first part (bone part and skin part) and a second part (body part). 600 mL (approximately twice the volume) of physiological saline was added to 300 g of each of the first site and the second site. The mixture was heated at 40° C. or 60° C. for 30 minutes, and subjected to filter paper filtration for solid-liquid separation to obtain exosome-containing compositions.
Although heating at 40° C. for 3 hours was attempted, there was a possibility of spoilage, so production of the composition containing exosomes was discontinued.
なお、40℃3時間加熱を試みたが、腐敗の可能性があったため、エクソソームを含む組成物の製造を中止した。 Three Fujinosuke pieces were processed and separated into a first part (bone part and skin part) and a second part (body part). 600 mL (approximately twice the volume) of physiological saline was added to 300 g of each of the first site and the second site. The mixture was heated at 40° C. or 60° C. for 30 minutes, and subjected to filter paper filtration for solid-liquid separation to obtain exosome-containing compositions.
Although heating at 40° C. for 3 hours was attempted, there was a possibility of spoilage, so production of the composition containing exosomes was discontinued.
得られたエクソソームの解析には、ナノ粒子解析システムを用いて行った。結果を表2に示す。なお、解析条件は上記と同様である。
The obtained exosomes were analyzed using a nanoparticle analysis system. The results are shown in Table 2. Note that the analysis conditions are the same as above.
処理温度を60℃とした場合には、微生物検査において、一般生菌数は0であり、大腸菌群、大腸菌、黄色ブドウ球菌は陰性との結果であったが、処理温度を40℃とした場合には、一般生菌数において、3.0~3.8×102の菌数が確認された。処理温度を60℃以上で行うことは、細菌やウイルス除去の観点で好ましい。
各微生物検査は、以下の手法により行った。
一般生菌数 標準寒天培地法
大腸菌群 合成酵素基質培地法
大腸菌 合成酵素基質培地法
黄色ブドウ球菌 卵黄加マンニット食塩培地法 When the processing temperature was set to 60°C, the number of general viable bacteria was 0 in the microbial test, and the results were negative for coliform bacteria, E. coli, and Staphylococcus aureus; however, when the processing temperature was set to 40°C In general, the number of viable bacteria was 3.0 to 3.8×10 2 . It is preferable to carry out the treatment at a temperature of 60° C. or higher from the viewpoint of removing bacteria and viruses.
Each microbial test was performed using the following method.
General viable bacteria count Standard agar medium method Coliform group Synthetic enzyme substrate medium method Escherichia coli Synthetic enzyme substrate medium method Staphylococcus aureus Mannitol salt medium method with egg yolk
各微生物検査は、以下の手法により行った。
一般生菌数 標準寒天培地法
大腸菌群 合成酵素基質培地法
大腸菌 合成酵素基質培地法
黄色ブドウ球菌 卵黄加マンニット食塩培地法 When the processing temperature was set to 60°C, the number of general viable bacteria was 0 in the microbial test, and the results were negative for coliform bacteria, E. coli, and Staphylococcus aureus; however, when the processing temperature was set to 40°C In general, the number of viable bacteria was 3.0 to 3.8×10 2 . It is preferable to carry out the treatment at a temperature of 60° C. or higher from the viewpoint of removing bacteria and viruses.
Each microbial test was performed using the following method.
General viable bacteria count Standard agar medium method Coliform group Synthetic enzyme substrate medium method Escherichia coli Synthetic enzyme substrate medium method Staphylococcus aureus Mannitol salt medium method with egg yolk
第1部位(骨部及び皮部)を用いて得られたエクソソームを含む組成物10μgをPBS(-)1mLに溶解して、エクソソーム溶液を得た。得られたエクソソーム溶液に、エタノール1.5mLを添加し、1M NaCl 2.25mLと、クロロホルム2.5mLを加え攪拌後、1,500gで10分間遠心し、上澄みを除去した。クロロホルムを留去した後、DAG(ジアシルグリセロール)アッセイキット(MET-5028)のAssay Buffer 50μLに溶解して、サンプル溶液を得た。サンプル溶液に対して、上記キットの説明書に従って操作を行い、Diacylglycerol(DAG)含量を解析した。脂肪間葉系幹細胞のエクソソーム(脂肪間葉系幹細胞EVs)をコントロールとして用いた。結果を図1に示す。なお、図1中、「FujinosukeEVs」は第1部位(骨部及び皮部)を用いて得られたエクソソームを意味する。
10 μg of the composition containing exosomes obtained using the first site (bone and skin) was dissolved in 1 mL of PBS(-) to obtain an exosome solution. To the obtained exosome solution, 1.5 mL of ethanol was added, 2.25 mL of 1M NaCl, and 2.5 mL of chloroform were added and stirred, followed by centrifugation at 1,500 g for 10 minutes, and the supernatant was removed. After distilling off the chloroform, it was dissolved in 50 μL of Assay Buffer of DAG (diacylglycerol) assay kit (MET-5028) to obtain a sample solution. The sample solution was operated according to the instructions of the kit, and the content of Diacylglycerol (DAG) was analyzed. Adipose mesenchymal stem cell exosomes (adipose mesenchymal stem cell EVs) were used as a control. The results are shown in Figure 1. In addition, in FIG. 1, "Fujinosuke EVs" means exosomes obtained using the first site (bone and skin).
北海道産の天然のシロザケと、青い森紅(くれない)サーモンと呼ばれる青森県産の養殖ニジマスを用いて、以下行った。
魚類を3枚卸に処理し、第1部位(頭部、骨部及び皮部)と、第2部位(身部)とに分離した。第1部位又は第2部位のそれぞれ300gに対して、生理食塩水600mL(約2倍量)を添加した。60℃で30分間加熱し、ろ紙ろ過を行って固液分離し、エクソソームを含む組成物をそれぞれ得た。なお、微生物検査において、一般生菌数は0であり、大腸菌群、大腸菌、黄色ブドウ球菌は陰性との結果であった。 The following was carried out using wild chum salmon from Hokkaido and farmed rainbow trout from Aomori Prefecture called Aomori Kurenai salmon.
Three pieces of fish were processed and separated into a first part (head, bone, and skin) and a second part (body). 600 mL (approximately twice the volume) of physiological saline was added to 300 g of each of the first site and the second site. The mixture was heated at 60° C. for 30 minutes and subjected to solid-liquid separation by filter paper filtration to obtain each composition containing exosomes. In addition, in the microbiological test, the general viable bacteria count was 0, and the results were negative for coliform bacteria, Escherichia coli, and Staphylococcus aureus.
魚類を3枚卸に処理し、第1部位(頭部、骨部及び皮部)と、第2部位(身部)とに分離した。第1部位又は第2部位のそれぞれ300gに対して、生理食塩水600mL(約2倍量)を添加した。60℃で30分間加熱し、ろ紙ろ過を行って固液分離し、エクソソームを含む組成物をそれぞれ得た。なお、微生物検査において、一般生菌数は0であり、大腸菌群、大腸菌、黄色ブドウ球菌は陰性との結果であった。 The following was carried out using wild chum salmon from Hokkaido and farmed rainbow trout from Aomori Prefecture called Aomori Kurenai salmon.
Three pieces of fish were processed and separated into a first part (head, bone, and skin) and a second part (body). 600 mL (approximately twice the volume) of physiological saline was added to 300 g of each of the first site and the second site. The mixture was heated at 60° C. for 30 minutes and subjected to solid-liquid separation by filter paper filtration to obtain each composition containing exosomes. In addition, in the microbiological test, the general viable bacteria count was 0, and the results were negative for coliform bacteria, Escherichia coli, and Staphylococcus aureus.
得られたエクソソームの解析には、ナノ粒子解析システムを用いて行った。結果を表3に示す。なお、解析条件は上記と同様である。
The obtained exosomes were analyzed using a nanoparticle analysis system. The results are shown in Table 3. Note that the analysis conditions are the same as above.
Claims (11)
- 40℃以上の水で魚類を処理する工程を含む、エクソソームを含む組成物の製造方法。 A method for producing a composition containing exosomes, which includes the step of treating fish with water at 40°C or higher.
- 50℃以上70℃以下で処理する、請求項1に記載の製造方法。 The manufacturing method according to claim 1, wherein the process is performed at a temperature of 50°C or higher and 70°C or lower.
- 前記魚類が、サケ科の魚類である、請求項1又は2に記載の製造方法。 The manufacturing method according to claim 1 or 2, wherein the fish is a salmonid fish.
- 前記魚類が、マスノスケ(キングサーモン)、シロザケ、ギンザケ、ベニザケ、ニジマス、サクラマス、ビワマス、クニマス、カラフトマス又はこれらの交配種である、請求項1又は2に記載の製造方法。 The production method according to claim 1 or 2, wherein the fish is a salmon salmon (king salmon), a chum salmon, a coho salmon, a sockeye salmon, a rainbow trout, a cherry salmon, a loquat trout, a black trout, a pink trout, or a hybrid thereof.
- 前記魚類が、マスノスケ(キングサーモン)及びニジマスの交配種である、請求項1又は2に記載の製造方法。 The production method according to claim 1 or 2, wherein the fish is a hybrid of King Salmon and Rainbow Trout.
- 前記魚類の、頭部、骨部及び皮部から選択される1つ以上の部位を用いる、請求項1又は2に記載の製造方法。 The manufacturing method according to claim 1 or 2, wherein one or more parts selected from the head, bone, and skin of the fish are used.
- 前記水が、生理食塩水である、請求項1又は2に記載の製造方法。 The manufacturing method according to claim 1 or 2, wherein the water is physiological saline.
- 50℃以上の水で、マスノスケ(キングサーモン)及びニジマスの交配種である富士の介の、頭部、骨部及び皮部から選択される1つ以上の部位を処理する工程を含む、富士の介からエクソソームを含む組成物を製造する方法。 Fujinosuke, which includes the step of treating one or more parts selected from the head, bone, and skin of Fujinosuke, which is a hybrid of King salmon and rainbow trout, with water at 50°C or higher. A method for producing a composition containing exosomes from a medium.
- 魚類由来のジアシルグリセロール含有エクソソームを含む、組成物。 A composition containing diacylglycerol-containing exosomes derived from fish.
- 前記ジアシルグリセロール含有量が、4pmol/1010粒子以上である、請求項9に記載の組成物。 The composition according to claim 9, wherein the diacylglycerol content is 4 pmol/10 10 particles or more.
- 前記ジアシルグリセロールが、炭素数18以上20以下の脂肪酸からなる群から選択される脂肪酸に由来する構造を有する、請求項9に記載の組成物。 The composition according to claim 9, wherein the diacylglycerol has a structure derived from a fatty acid selected from the group consisting of fatty acids having 18 or more and 20 or less carbon atoms.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022-105342 | 2022-06-30 | ||
JP2022105342 | 2022-06-30 | ||
JP2022164968 | 2022-10-13 | ||
JP2022-164968 | 2022-10-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024005199A1 true WO2024005199A1 (en) | 2024-01-04 |
Family
ID=89382549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2023/024458 WO2024005199A1 (en) | 2022-06-30 | 2023-06-30 | Method for producing composition comprising exosome, and composition comprising diacylglycerol-containing exosome |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024005199A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09173007A (en) * | 1995-12-26 | 1997-07-08 | Nichiro Corp | Extract-based seasoning having improved seasoning property and its production |
JP2005333813A (en) * | 2004-05-24 | 2005-12-08 | Masashi Osada | Functional food and method for producing the same |
-
2023
- 2023-06-30 WO PCT/JP2023/024458 patent/WO2024005199A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09173007A (en) * | 1995-12-26 | 1997-07-08 | Nichiro Corp | Extract-based seasoning having improved seasoning property and its production |
JP2005333813A (en) * | 2004-05-24 | 2005-12-08 | Masashi Osada | Functional food and method for producing the same |
Non-Patent Citations (1)
Title |
---|
ANONYMOUS: "[Aozora Restaurant] How to make Fujinosuke's "Soymilk hot pot"/Yamanashi Prefecture, Fujinosuke ", 28 March 2020 (2020-03-28), XP093121990, Retrieved from the Internet <URL:https://rinrinto.com/aozora-20200328-5-11088> * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chaklader et al. | The ameliorative effects of various fish protein hydrolysates in poultry by-product meal based diets on muscle quality, serum biochemistry and immunity in juvenile barramundi, Lates calcarifer | |
Guedes et al. | Application of microalgae protein to aquafeed | |
JP5096656B2 (en) | Marine lipid composition for aquatic feeding | |
JP4201349B2 (en) | Microbial preparations containing omega-3-fatty acids for use as preventive or therapeutic agents for animal parasitic diseases | |
Balfry et al. | Influence of dietary lipid composition on the immune system and disease resistance of finfish | |
US11930832B2 (en) | Feed supplement material for use in aquaculture feed | |
Kołakowska et al. | Some of fish species as a source of n-3 polyunsaturated fatty acids | |
JP4778792B2 (en) | Animal plankton feed | |
Estévez et al. | Effects of alternative and sustainable ingredients, insect meal, microalgae and protein and lipid from tuna cooking water, on meagre (Argyrosomus regius) growth, food conversion and muscle and liver composition | |
Nahavandi et al. | Investigation of the effect of diet containing Red algae (Laurencia caspica) on blood parameters and activity of digestive enzymes of goldfish (Carassius auratus) | |
JP2014503562A (en) | Sexual function improver | |
JP2003012520A (en) | Antioxidant and food and drink containing the same | |
Kumar et al. | Applications of microalgae in aquaculture feed | |
WO2024005199A1 (en) | Method for producing composition comprising exosome, and composition comprising diacylglycerol-containing exosome | |
Islam et al. | Mucosal barrier status in Atlantic salmon fed rapeseed oil and Schizochytrium oil partly or fully replacing fish oil through winter depression | |
EP0519916B1 (en) | Process for enrichment of fat with regard to polyunsaturated fatty acids and phospholipids, and application of such enriched fat | |
Nath et al. | Fatty acid compositions of four edible fishes of Hooghly Estuary, West Bengal, India | |
Shahidi et al. | Marine oils: compositional characteristics and health effects | |
KR102333548B1 (en) | Animal feed composition comprising bass extract and preparation method thereof | |
JP2010105946A (en) | Muscle protein enhancer and drug or food containing the same | |
TWI822836B (en) | A composition containing the plasmalogen, which for enhancing memorizing capability | |
JPH09308459A (en) | Nutritive composition containing highly unsaturated fatty acid | |
JP2004516272A5 (en) | ||
JP7466852B2 (en) | Methods for Producing Compositions Comprising Collagen Peptides | |
Noor El-Deen et al. | Efficacy of Algal Nutrition on Crustacean Infestation of Some Cultured Marine Fish, Ismailia Governorate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23831638 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2024531001 Country of ref document: JP Kind code of ref document: A |